Faculty Profiles - HATAKEYAMA SHINGO

Papers - HATAKEYAMA SHINGO

Division display >> ／ All the affair displays1 - 540 of about 540

A Novel Strategy for Evasion of NK Cell Immunity by Tumours Expressing Core2 O-glycans.

Tsuboi S, Sutoh M, Hatakeyama S, Hiraoka N, Habuchi T, Horikawa Y, Hashimoto Y, Yoneyama T, Mori K, Koie T, Nakamura T, Saitoh H, Yamaya K, Funyu T, Fukuda M and Ohyama C.

EMBO J 2011.6

Perioperative Factors Associated With Postoperative Delirium in Patients Undergoing Noncardiac Surgery: An Individual Patient Data Meta-Analysis.

Sadeghirad B, Dodsworth BT, Schmutz Gelsomino N, Goettel N, Spence J, Buchan TA, Crandon HN, Baneshi MR, Pol RA, Brattinga B, Park UJ, Terashima M, Banning LBD, Van Leeuwen BL, Neerland BE, Chuan A, Martinez FT, Van Vugt JLA, Rampersaud YR, Hatakeyama S, Di Stasio E, Milisen K, Van Grootven B, van der Laan L, Thomson Mangnall L, Goodlin SJ, Lungeanu D, Denhaerynck K, Dhakharia V, Sampson EL, Zywiel MG, Falco L, Nguyen AV, Moss SJ, Krewulak KD, Jaworska N, Plotnikoff K, Kotteduwa-Jayawarden S, Sandarage R, Busse JW, Mbuagbaw L.

2023.8

Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes.

Bao X, Moseman EA, Saito H, Petryanik B, Thiriot A, Hatakeyama S, Ito Y, Kawashima H, Yamaguchi Y, Lowe JB, von Andrian UH, Fukuda M.

Immunity. 2010.11

Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.

Bao X, Kobayashi M, Hatakeyama S, Angata K, Gullberg D, Nakayama J, Fukuda MN, Fukuda M.　

Proc Natl Acad Sci U S A. 21 ( 7 ) 12109 - 12114 2009.7

Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cells

Hatakeyama S, Kazuhiro Sugihara, Jun Nakayama , Tomoya O. Akama, Suk-Man Annie Wong, Hiroto Kawashima, Jianing Zhang , David F. Smith, Chikara Ohyama, Minoru Fukuda, and Michiko N. Fukuda.

Proc Natl Acad Sci U S A. 106 ( 9 ) 3095 - 3100 2009.3

Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study.

Sazuka T, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Sawada A, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Ichikawa T, Japan Urological Oncology Group

International journal of clinical oncology 30 ( 7 ) 1417 - 1425 2025.7

Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.

Takahashi M, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Yamashita S, Taniguchi H, Monji K, Ishiyama R, Kawasaki Y, Kato T, Tatarano S, Masui K, Nakamura E, Kaneko T, Miyake M, Kitano G, Motoshima T, Shiraishi Y, Kira S, Murashima T, Hara H, Matsumura M, Kitamura H, Miyake H, Furukawa J, Japanese Urological Oncology Group

Clinical genitourinary cancer 23 ( 3 ) 102322 2025.6

PD-L1 and Ki-67 Expression Before and After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.

Sasaki D, Yoneyama T, Yoneyama F, Ozaki K, Ozaki Y, Miura Y, Fujita N, Okamoto T, Yamamoto H, Goto S, Yoshizawa T, Kurose A, Kijima H, Ohyama C, Hatakeyama S

International journal of urology : official journal of the Japanese Urological Association 2025.5

Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study.

Yoneyama F, Shinohara M, Kawashima Y, Yoneyama A, Ishii N, Oishi T, Tanaka R, Miura H, Kodama H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Sato S, Ohyama C, Hatakeyama S

International journal of urology : official journal of the Japanese Urological Association 2025.5

Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy.

Hatakeyama S, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga KI, Yamaguchi N, Taguchi M, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Ohyama C, Japanese Urological Oncology Group

Cancer medicine 14 ( 9 ) e70782 2025.5

Analytical and Real-World Clinical Characterization of S2,3PSA% Test in MRI Fusion Targeted Prostate Biopsy Population.

Yuki Miura, Tohru Yoneyama, Hayato Yamamoto, Hiromu Suzuki, Takuma Otsubo, Eriko Fujita, Fumiyasu Tsushima, Shintaro Goto, Teppei Okamoto, Naoki Fujita, Masahiro Ishiyama, Tadashi Yoshizawa, Shingo Kakeda, Shingo Hatakeyama, Chikara Ohyama

The Prostate 85 ( 9 ) 869 - 887 2025.3

Estimating the Morbidity of Robot-Assisted Radical Cystectomy Using the Comprehensive Complication Index: Data from the Asian Robot-Assisted Radical Cystectomy Consortium.

Yuanming AL, Na FTB, Tiwari R, Chan TKN, Teoh JY, Kang SH, Patel MI, Muto S, Yang CK, Hatakeyama S, Kijvikai K, Chen H, Ohyama C, Horie S, Chan ES, Lee LS

Cancers 17 ( 7 ) 2025.3

Multicenter, international, retrospective study of prognostic factors for Ra223.

Oishi T, Luo HL, Hatayama Y, Kawaguchi H, Sasaki D, Tanaka R, Ishii N, Mikami J, Okamoto T, Yamamoto H, Aoki M, Su YL, Chen YH, Chang YH, Chen YT, Wang HJ, Ohyama C, Hatakeyama S

Scientific reports 15 ( 1 ) 10814 2025.3

Pre-transplant tacrolimus fluctuations predict BK virus infection risk in kidney transplants.

Hisashi Sakurai, Teppei Okamoto, Anna Yonemaya, Fumiya Yonemaya, Tomoko Hamaya, Hirotake Kodama, Naoki Fujita, Hayato Yamamoto, Kazuyuki Mori, Takeshi Fujita, Atushi Imai, Reiichi Murakami, Hirofumi Tomita, Shingo Hatakeyama, Chikara Ohyama

Clinical and experimental nephrology 29 ( 7 ) 987 - 994 2025.3

Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter Study.

Ozaki K, Yamamoto H, Sekine Y, Horiguchi H, Hosogoe S, Mikami J, Fujita N, Tokui N, Okita K, Okamoto T, Mori K, Kobayashi M, Numakura K, Yoneyama T, Tabata R, Sato S, Habuchi T, Ohyama C, Hatakeyama S.

Int J Urol 32 2025.3

Efficacy of valganciclovir prophylaxis in kidney transplant recipients following low-dose rituximab induction therapy: a multicenter retrospective study.

Takehara T, Nishida H, Ichikawa K, Nawano T, Takai S, Fukuhara H, Matsuura T, Maita S, Saito M, Murakami R, Hatakeyama S, Obara W, Saitoh H, Ohyama C, Habuchi T, Watanabe M, Tsuchiya N.

Clin Exp Nephrol. 29 2025.3

Penile metastasis from a duodenal gastrointestinal stromal tumor: A rare case report.

Yoneyama F, Okamoto T, Hamaya T, Kodama H, Fujita N, Yamamoto H, Imai A, Hatakeyama S.

2025.2

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.

Hara S, Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group.

32 2025.2

Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.

Kikuchi H, Osawa T, Matsushita Y, Kojima T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Ueda K, Tanaka H, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Kato T, Hara H, Ito Y, Kitamura H, Miyake H, Shinohara N

2025.2

Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone-sensitive prostate cancer: A multicenter study.

Yanagisawa T, Fukuokaya W, Hatakeyama S, Narita S, Muramoto K, Katsumi K, Takahashi H, Urabe F, Mori K, Tashiro K, Iwatani K, Shimomura T, Habuchi T, Kimura T.

Prostate. 85 2025.2

Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma.

Mori K, Numakura K, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Yamana K, Kandori S, Kimura T, Nishiyama N, Bando Y, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Kitamura H, Miyake H, Habuchi T.

Cancer Sci. 116 2025.2

特集今のうちにしっかり理解　最新の前立腺癌診療と近未来予想図〈治療〉高リスク前立腺癌に対するネオアジュバント内分泌化学療法を用いた手術療法

米山高弘, 山本勇人, 畠山真吾

臨床泌尿器科 79 ( 1 ) 56 - 62 2025.1

特集今のうちにしっかり理解　最新の前立腺癌診療と近未来予想図企画にあたって今のうちにしっかり理解　最新の前立腺癌診療と近未来予想図

畠山真吾

臨床泌尿器科 79 ( 1 ) 5 - 5 2025.1

Prognostic model for second progression-free survival and overall survival in patients with high-risk metastatic hormone-sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy. 🗍

85 73 2025.1

Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer.

Miura H, Yamamoto H, Okuyama Y, Ishi N, Tanaka R, Oishi T, Yoneyama F, Hamaya T, Togashi K, Fujita N, Okamoto T, Ohyama C, Hatakeyama S

Cancer medicine 13 ( 24 ) e70226 2024.12

The first detailed annual record on the National Clinical Database Urology Division in Japan: A report on five surgical procedures.

Kikuchi E, Yamamoto H, Yasui T, Hatakeyama S, Mizuno R, Sakamoto S, Mizuno K, Morizane S, Hayakawa N, Kobayashi T, Kamoto T, Eto M

International journal of urology : official journal of the Japanese Urological Association 31 ( 12 ) 1344 - 1355 2024.12

Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter study.

🗍� Kato M, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Yamamoto S, Matsue T, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Uchida J; Japan Urological Oncology Group.

Int J Clin Oncol. 2024.12

Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer. 🗍

Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T.

31 2024.12

Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy

Miura H, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Moriyama S, Oishi T, Horiguchi H, Soma O, Noro D, Tanaka T, Okamoto T, Yamamoto H, Sato S, Ohyama C.

Int J Urol 31 1330-1336 2024.12

Annual record on the number of general urological surgeries registered in the National Clinical Database system between April 2018 and December 2021 in Japan

Yasui T, Kikuchi E, Yamamoto H, Ishii D, Mizuno R, Hatakeyama S, Kobayashi T, Uchida J, Takahashi M, Sakamoto S, Morizane S, Kamoto T, Eto M.

Int J Urol. 31 1256-1262 2024.11

Clinical significance of PSA dynamics in castration-sensitive prostate cancer treated with ARSI doublet therapy: A multicenter study.

Urabe F, Hatakeyama S, Yanagisawa T, Narita S, Muramoto K, Katsumi K, Takahashi H, Fukuokaya W, Mori K, Tashiro K, Iwatani K, Shimomura T, Miki J, Habuchi T, Kimura T; JHA Collaborative Group.

Urol Oncol 2024.10

Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study

Miki J, Fukuokaya W, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group.

31 ( 9 ) 1009-1016. 2024.9

Long-Term Outcomes of Orthotopic Neobladder Versus Ileal Conduit Urinary Diversion in Robot-Assisted Radical Cystectomy (RARC): Multicenter Results from the Asian RARC Consortium.

31 2024.9

Pre-Op Hydronephrosis Predicts Outcomes in Patients Receiving Robot-Assisted Radical Cystectomy. 🗍

Wong CH, Ko IC, Leung DK, Kang SH, Kitamura K, Horie S, Muto S, Ohyama C, Hatakeyama S, Patel M, Yang CK, Kijvikai K, Lee JY, Chen HG, Zhang RY, Lin TX, Lee LS, Teoh JY, Chan E.

16 2826 2024.8

Prognostic impact of histological discordance between transurethral resection and radical cystectomy

Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y; Japanese Urological Oncology Group.

BJU Int 134 ( 2 ) 207-218 2024.8

Associations of remaining teeth number, periodontal disease, and occlusal support status with erectile dysfunction in community-dwelling men

Fujita N, Iwane T, Tamura Y, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Kobayashi W, Ohyama C.

Int J Urol. 31 2024.8

TOPICS 泌尿器科学前立腺癌の新規体外診断薬S2,3PSA%

大山力, 米山徹, 畠山真吾

医学のあゆみ 290 ( 2 ) 182 - 183 2024.7

トピックス新規前立腺癌診断マーカー S2,3PSA%の有用性

畠山真吾, 米山徹, 大山力

検査と技術 52 ( 6 ) 568 - 570 2024.6

Association between sex hormones and erectile dysfunction in men without hypoandrogenism

Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Mikami T, Itoh K, Ohyama C, Hatakeyama S.

Sci Rep 14 13433 2024.6

Impact of severe acute kidney injury on short-term mortality in urosepsis

42 2024.5

Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association.

Mori K, Hatakeyama S, Enokida H, Miyake H, Kikuchi E, Nishiyama H, Ichikawa T, Kamai T, Kaji Y, Kume H, Kondo T, Matsuyama H, Masumori N, Kawauchi A, Takenaka A, Uemura H, Eto M, Nonomura N, Fujii Y, Hinotsu S, Ohyama C.

2024.3

Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2

Kikuchi Y, Shimada H, Yamasaki F, Yamashita T, Araki K, Horimoto K, Yajima S, Yashiro M, Yokoi K, Cho H, Ehira T, Nakahara K, Yasuda H, Isobe K, Hayashida T, Hatakeyama S, Akakura K, Aoki D, Nomura H, Tada Y, Yoshimatsu Y, Miyachi H, Takebayashi C, Hanamura I, Takahashi H.

Int J Clin Oncol. 2024.3

Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic

2024.3

Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study

Fujita N, Hatakeyama S, Tabata R, Okita K, Kido K, Hamano I, Tanaka T, Noro D, Tokui N, Suzuki Y, Yoneyama T, Hashimoto Y, Sato S, Ohyama C.

12 ( 1 ) 46 2024.3

Share Prognostic impact of histological discordance between transurethral resection and radical cystectomy

2024.2

Incidence of postoperative cytomegalovirus and BK-polyoma virus infections and graft loss in ABO-incompatible renal transplant recipients: a multicenter retrospective study

Kodama H, Hatakeyama S, Matsuura T, Saito M, Nishida H, Hamaya T, Maita S, Murakami R, Tomita H, Saitoh H, Tsuchiya N, Habuchi T, Obara W, Ohyama C.

2024.2

Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.

Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Nishiyama N, Kimura T, Yamashita S, Kitamura H, Miyake H; Japanese Urological Oncology Group.

2024.1

Association between oral frailty and lower urinary tract symptoms among middle-aged and older adults in community-dwelling individuals: a cross-sectional study.

Yoneyama F, Okamoto T, Tamura Y, Ishii N, Togashi K, Soma O, Fujita N, Yamamoto H, Hatakeyama S, Kobayashi W, Ohyama C.

2024.1

Impact of timing of rejection episode on cardiovascular events in living donor kidney transplantation: a multicenter retrospective study.

Okamoto T, Hatakeyama S, Hamaya T, Matsuura T, Saito M, Nishida H, Maita S, Murakami R, Tomita H, Saitoh H, Tsuchiya N, Habuchi T, Obara W, Ohyama C.

2023.12

Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study.

Sazuka T, Matsushita Y, Sato H, Osawa T, Hinata N, Hatakeyama S, Numakura K, Ueda K, Kimura T, Takahashi M, Tanaka H, Kawasaki Y, Kurahashi T, Kato T, Fujita K, Miyake M, Kojima T, Kitamura H, Miyake H, Ichikawa T.

2023.11

Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.

Tanaka R, Hatakeyama S, Narita S, Sakurai T, Tanaka T, Miura H, Oishi T, Kawamura S, Hoshi S, Ishidoya S, Mitsuzuka K, Ito A, Tsuchiya N, Habuchi T, Ohyama C.

2023.11

Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.

Kobayashi M, Numakura K, Hatakeyama S, Ishida T, Koizumi A, Tadachi K, Igarashi R, Takayama K, Muto Y, Sekine Y, Sobu R, Sasagawa H, Akashi H, Kashima S, Yamamoto R, Nara T, Saito M, Narita S, Ohyama C, Habuchi T.

2023.11

Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group.

Horie S, Naito S, Hatakeyama S, Kandori S, Numakura K, Kato R, Koguchi T, Myoen S, Kawasaki Y, Ito A, Adachi H, Kojima Y, Obara W, Habuchi T, Nishiyama H, Ohyama C, Tsuchiya N.

2023.11

The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database.

Koguchi T, Naito S, Hatakeyama S, Numakura K, Muto Y, Kato R, Kojima T, Kawasaki Y, Morozumi K, Kandori S, Kawamura S, Nishiyama H, Ito A, Habuchi T, Obara W, Ohyama C, Tsuchiya N, Kojima Y.

2023.11

Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site.

Nishiyama N, Kita Y, Ito K, Kato M, Hatakeyama S, Matsushita Y, Naito S, Miyake M, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Taoka R, Nishiyama H, Kobayashi T, Kitamura H; Japan Urological Oncology Group.

2023.11

Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab.

Hamaya T, Hatakeyama S, Yoneyama T, Tobisawa Y, Kodama H, Fujita T, Murakami R, Mori K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C.

Sci Rep. 2023.9

学会印象記「第110回日本泌尿器科学会総会」印象記

畠山真吾

臨床泌尿器科 77 ( 9 ) 739 - 741 2023.8

Think different in urinary stone treatment 尿路結石形成の解明と治療への応用を目指して

畠山真吾, 米山徹, 大山力

泌尿器外科 36 ( 臨増 ) 732 - 733 2023.8

「Stone freeを目指すための様々なアプローチ」抗炎症作用に着目したアプローチ

阿南剛, 廣瀬卓男, 米山徹, 菊池大輔, 畠山真吾, 佐藤信, 森建文, 大山力

日本尿路結石症学会学術集会プログラム・抄録集 33回 33 - 33 2023.8

Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma.

Numakura K, Sekine Y, Hatakeyama S, Muto Y, Sobu R, Kobayashi M, Sasagawa H, Kashima S, Yamamto R, Nara T, Akashi H, Tabata R, Sato S, Saito M, Narita S, Ohyama C, Habuchi T

Cancer medicine 2023.7

Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.

Tanaka R, Hatakeyama S, Narita S, Sakurai T, Tanaka T, Miura H, Oishi T, Kawamura S, Hoshi S, Ishidoya S, Mitsuzuka K, Ito A, Tsuchiya N, Habuchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 2023.7

Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version).

Harada H, Fukuzawa N, Abe T, Imamura R, Masaki N, Fujiyama N, Sato S, Hatakeyama S, Nishimura K, Kishikawa H, Iwami D, Hotta K, Miura M, Ide K, Nakamura M, Kosoku A, Uchida J, Murakami T, Tsuji T

BMC nephrology 24 ( 1 ) 158 2023.6

Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study.

Okuyama Y, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka T, Fujita N, Okamoto T, Mori K, Yamamoto H, Yoneyama T, Hashimoto Y, Matsuoka T, Sato S, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 2023.5

Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi‑institutional retrospective study.

Renpei Kato, Sei Naito, Kazuyuki Numakura, Shingo Hatakeyama, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Shuya Kandori, Sadafumi Kawamura, Yoichi Arai, Akihiro Ito, Hiroyuki Nishiyama, Yoshiyuki Kojima, Chikara Ohyama, Tomonori Habuchi, Norihiko Tsuchiya, Wataru Obara

International journal of clinical oncology 28 ( 5 ) 726 - 727 2023.5

Relationship between lower urinary tract symptoms and frailty.

Ozaki Y, Hatakeyama S, Imai A, Songee J, Soma O, Ozaki K, Fujita N, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 2023.4

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

The world journal of men's health 41 ( 2 ) 373 - 381 2023.4

Development of a minimally invasive medical system for urological malignancies for an aging society

Hirosaki Medical Journal 73 ( 1-4 ) 94 - 96 2023.3

特集最新版!　筋層浸潤性膀胱癌の診断と治療-アンメットニーズはどこまで埋まったか〈治療〉筋層浸潤性膀胱癌に対する周術期全身療法-ネオアジュバント・アジュバント治療の進歩

畠山真吾

臨床泌尿器科 77 ( 3 ) 226 - 233 2023.3

Trends in the age of hospitalized patients with urological cancers: A 17-year experience.

Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 2023.3

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy.

Oishi T, Hatakeyama S, Tabata R, Fujimori D, Fukuda M, Shinozaki T, Ishii N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C

Scientific reports 13 ( 1 ) 3436 2023.3

Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.

Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Translational andrology and urology 12 ( 2 ) 161 - 167 2023.2

Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study.

Fujita N, Momota M, Horiguchi H, Hamano I, Mikami J, Hatakeyama S, Ito H, Yoneyama T, Hashimoto Y, Nishimura S, Yoshikawa K, Ohyama C

Cancers 15 ( 5 ) 2023.2

Prognostic value of immune phenotype and PD-L1 status in recurrent or metastatic renal cell carcinoma: an exploratory analysis of the ARCHERY study.

Tsuzuki T, Ohe C, Osawa T, Yasuda Y, Tanaka T, Anai S, Kimura G, Yamana K, Hatakeyama S, Yoshimoto T, Nakagawa Y, Fukuyama T, Matsubara N, Uemura H

Pathology 55 ( 1 ) 31 - 39 2023.2

Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study.

Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C

The Prostate 83 ( 2 ) 198 - 203 2023.2

Clinical impact of early response to first-line VEGFR-TKI in patients with metastatic renal cell carcinoma on survival: A multi-institutional retrospective study.

Sobu R, Numakura K, Naito S, Hatakeyama S, Kato R, Koguchi T, Kojima T, Kawasaki Y, Kandori S, Kawamura S, Arai Y, Ito A, Nishiyama H, Kojima Y, Obara W, Ohyama C, Tsuchiya N, Habuchi T

Cancer medicine 12 ( 4 ) 4100 - 4109 2023.2

Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy.

Yanagisawa T, Hata K, Narita S, Hatakeyama S, Mori K, Yata Y, Sano T, Otsuka T, Hara S, Miyajima K, Enei Y, Fukuokaya W, Nakazono M, Matsukawa A, Miki J, Habuchi T, Ohyama C, Shariat SF, Kimura T

The Prostate 2023.1

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study.

Fujita N, Momota M, Ozaki Y, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

The world journal of men's health 2023.1

Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction.

Fujita N, Ishida M, Iwane T, Suganuma H, Matsumoto M, Hatakeyama S, Yoneyama T, Hashimoto Y, Mikami T, Itoh K, Ohyama C

The world journal of men's health 2023.1

Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.

Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C

World journal of urology 41 ( 1 ) 67 - 75 2023.1

[Ⅱ. Update on Guideline for Management of Metastatic Urothelial Carcinoma].

Hatakeyama S, Ohyama C

Gan to kagaku ryoho. Cancer & chemotherapy 50 ( 1 ) 45 - 49 2023.1

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

PloS one 18 ( 2 ) e0275921 2023

イムノグロブリン<i>N</i>型糖鎖プロファイルを基盤とした機械学習アプローチによる腎移植後の拒絶予測モデルの開発

小玉寛健, 米山徹, 岩村大径, 藤田尚紀, 田中壽和, 畠山真吾, 柿崎育子, 大山力

移植 58 ( Supplement ) s226_2 - s226_2 2023

血縁間生体腎移植と非血縁間生体腎移植の臨床的検討：多施設共同研究 Michinoku Renal Transplant Network, MRTN

豊嶋萌, 松浦朋彦, 齋藤満, 西田隼人, 畠山真吾, 米田真也, 村上礼一, 杉村淳, 阿部貴弥, 富田泰史, 齋藤久夫, 土谷順彦, 大山力, 羽渕友則, 小原航

移植 58 ( Supplement ) s305_1 - s305_1 2023

ABO不適合生体腎移植の術後ウイルス感染症と予後の検討

小玉寛健, 畠山真吾, 松浦朋彦, 齋藤満, 西田隼人, 米田真也, 村上礼一, 富田泰史, 齋藤久夫, 土谷順彦, 羽渕友則, 小原航, 大山力

移植 58 ( Supplement ) s268_1 - s268_1 2023

65歳以上生体腎移植の治療成績の検討：Michinoku Renal Transplant Network, MRTN

高井諭, 西田隼人, 松浦明彦, 福原宏樹, 齋藤満, 畠山真吾, 米田真也, 村上礼一, 齋藤久夫, 大山力, 羽渕朋則, 小原航, 土谷順彦

移植 58 ( Supplement ) s256_2 - s256_2 2023

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers.

Togashi K, Hatakeyama S, Soma O, Okita K, Fujita N, Tanaka T, Noro D, Horiguchi H, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Cancers 14 ( 24 ) 2022.12

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction.

Miura H, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Tanaka R, Noro D, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology 2022.12

Testicular teratomagenesis from primordial germ cells with overexpression of germinal center-associated nuclear protein.

Sakai Y, Yoshinaga K, Yoshida A, Rezano A, Shiogama K, Kawashima Y, Yoshizawa T, Yoshizawa A, Hatakeyama S, Ohyama C, Ito H, Abe M, Kijima H, Otsuki Y, Ito A, Tsuzuki T, Takeya M, Sakaguchi N, Kuwahara K

Cancer science 2022.12

Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.

Takahashi S, Narita S, Fujiyama N, Hatakeyama S, Kobayashi T, Kato R, Naito S, Sakatani T, Kashima S, Koizumi A, Yamamoto R, Nara T, Kanda S, Numakura K, Saito M, Obara W, Tsuchiya N, Ohyama C, Ogawa O, Habuchi T

Cancer science 113 ( 12 ) 4059 - 4069 2022.12

Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

The aging male : the official journal of the International Society for the Study of the Aging Male 25 ( 1 ) 1 - 7 2022.12

Association of oxidative stress with erectile dysfunction in community-dwelling men and men on dialysis.

Fujita N, Momota M, Ishida M, Iwane T, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Yamaya K, Ohyama C

The aging male : the official journal of the International Society for the Study of the Aging Male 25 ( 1 ) 193 - 201 2022.12

Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis.

Fujita N, Hatakeyama S, Momota M, Hamaya T, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Andrology 10 ( 8 ) 1548 - 1555 2022.11

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids.

Ishii N, Hatakeyama S, Yoneyama T, Tanaka R, Narita T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology 40 ( 10 ) 451.e1 - 451.e8 2022.10

Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancer.

Yanagisawa T, Kimura T, Hata K, Narita S, Hatakeyama S, Enei Y, Atsuta M, Mori K, Obayashi K, Yoshihara K, Kondo Y, Oguchi T, Sadakane I, Habuchi T, Ohyama C, Shariat SF, Egawa S

The Prostate 82 ( 14 ) 1322 - 1330 2022.10

Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy.

Narita S, Terada N, Nomura K, Sakamoto S, Hatakeyama S, Kato T, Matsui Y, Inokuchi J, Yokomizo A, Tabata KI, Shiota M, Kimura T, Kojima T, Inoue T, Mizowaki T, Sugimoto M, Kitamura H, Kamoto T, Nishiyama H, Habuchi T, Japanese Urological Oncology Group

International journal of urology : official journal of the Japanese Urological Association 29 ( 10 ) 1147 - 1154 2022.10

Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomy.

Tanaka R, Hatakeyama S, Miura H, Hamaya T, Yoneyama T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 29 ( 10 ) 1235 - 1237 2022.10

尿路上皮癌・腎癌患者におけるSARSCoV-2ワクチンの血清反応に対する薬物療法の影響

富樫赳, 畠山真吾, 米山徹, 濱谷智子, 成田拓磨, 藤田尚紀, 岩村大径, 岡本哲平, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本癌治療学会学術集会抄録集 60回 P87 - 5 2022.10

転移性腎癌におけるイピリムマブ・ニボルマブ併用療法の早期の耐性化と関連因子の検討

武藤弓奈, 沼倉一幸, 畠山真吾, 関根悠哉, 小林瑞貴, 嘉島相輝, 山本竜平, 奈良健平, 齋藤満, 成田伸太郎, 大山力, 羽渕友則

日本癌治療学会学術集会抄録集 60回 P51 - 1 2022.10

本邦における転移性去勢感受性前立腺癌患者に対するup-front治療の有用性

佐藤博美, 成田伸太郎, 木村高弘, 畠山真吾, 畠憲一, 柳澤孝文, 岡根克己, 石田俊哉, 堀川洋平, 熊沢光明, 下田次郎, 鈴木丈博, 大山力, 頴川晋, 羽渕友則

日本癌治療学会学術集会抄録集 60回 YOA O39 - 4 2022.10

ADT単独またはupfront治療を受けた去勢感受性転移性前立腺癌患者の健康関連QOL

石田雅宣, 成田伸太郎, 畠山真吾, 米田真也, 千葉修治, 小泉淳, 岡根克己, 石田俊哉, 堀川洋平, 熊澤光明, 秋濱晋, 下田次郎, 鈴木丈博, 大山力, 羽渕友則

日本癌治療学会学術集会抄録集 60回 P95 - 6 2022.10

Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Miura Y, Hatakeyama S, Narita S, Kimura T, Hata K, Yanagisawa T, Tanaka T, Ishi N, Kawamura S, Hoshi S, Ishidoya S, Mitsuzuka K, Ito A, Tsuchiya N, Egawa S, Habuchi T, Ohyama C

The Prostate 82 ( 13 ) 1304 - 1312 2022.9

Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel.

Narita S, Kimura T, Hatakeyama S, Hata K, Yanagisawa T, Maita S, Chiba S, Sato H, Kashima S, Koizumi A, Yamamoto R, Takayama K, Okane K, Ishida T, Horikawa Y, Kumazawa T, Shimoda J, Suzuki T, Ohyama C, Egawa S, Habuchi T

International journal of clinical oncology 27 ( 9 ) 1477 - 1486 2022.9

Predicting perioperative outcomes of robot-assisted radical cystectomy: Data from the Asian Robot-Assisted Radical Cystectomy Consortium.

Lee AY, Allen JC Jr, Teoh JY, Kang SH, Patel MI, Muto S, Yang CK, Hatakeyama S, Zhang R, Kijvikai K, Chen H, Ohyama C, Horie S, Chan ES, Lee LS

International journal of urology : official journal of the Japanese Urological Association 29 ( 9 ) 1002 - 1009 2022.9

周術期に血小板減少症を生じた腎移植ドナーの一例

小玉寛健, 岡本哲平, 山本勇人, 藤田雄, 村上礼一, 畠山真吾, 米山高弘, 橋本安弘, 大山力

泌尿器外科 35 ( 9 ) 1024 - 1024 2022.9

診断に苦慮した右腎腫瘍の1例

小西栄, 岩村大径, 尾崎佑輔, 沖田和貴, 小玉寛健, 成田拓磨, 小島由太, 藤田尚紀, 岡本哲平, 山本勇人, 畠山真吾, 米山高弘, 橋本安弘, 大山力

泌尿器外科 35 ( 9 ) 1022 - 1022 2022.9

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Scientific reports 12 ( 1 ) 13786 2022.8

Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.

Fujita N, Hatakeyama S, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 29 ( 8 ) 867 - 875 2022.8

Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.

Kobayashi M, Narita S, Matsui Y, Kanda S, Hidaka Y, Abe H, Tsuzuki T, Ito K, Kojima T, Kato M, Hatakeyama S, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Taoka R, Kamiyama M, Morita S, Habuchi T, Ogawa O, Nishiyama H, Kitamura H, Kobayashi T, Japan Urological Oncology Group

BJU international 130 ( 2 ) 226 - 234 2022.8

Selective reaction monitoring approach using structure-defined synthetic glycopeptides for validating glycopeptide biomarkers pre-determined by bottom-up glycoproteomics.

Shiratori K, Yokoi Y, Wakui H, Hirane N, Otaki M, Hinou H, Yoneyama T, Hatakeyama S, Kimura S, Ohyama C, Nishimura SI

RSC advances 12 ( 33 ) 21385 - 21393 2022.7

TMEM2 expression is downregulated as bladder cancer invades the muscle layer.

Yoneyama MS, Yoneyama T, Tobisawa Y, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Suzuki T, Ohyama C

Biochemical and biophysical research communications 613 1 - 6 2022.7

Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism.

Kobayashi M, Numakura K, Hatakeyama S, Muto Y, Sekine Y, Sasagawa H, Kashima S, Yamamoto R, Koizumi A, Nara T, Saito M, Narita S, Ohyama C, Habuchi T

Genes 13 ( 7 ) 2022.7

Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.

Iwamura H, Mizuno K, Akamatsu S, Hatakeyama S, Tobisawa Y, Narita S, Narita T, Yamashita S, Kawamura S, Sakurai T, Fujita N, Kodama H, Noro D, Kakizaki I, Nakaji S, Itoh K, Tsuchiya N, Ito A, Habuchi T, Ohyama C, Yoneyama T

Cancer science 113 ( 7 ) 2434 - 2445 2022.7

Kidney Transplantation in a Patient With Noonan Syndrome: A Case Report.

Kodama H, Hatakeyama S, Hamaya T, Murakami R, Murasawa H, Yamamoto H, Yoneyama T, Ohyama C

Transplantation proceedings 54 ( 6 ) 1601 - 1603 2022.7

尿意切迫感と眼瞼下垂の関係岩木町健康増進プロジェクトの結果から

尾崎佑輔, 岡本哲平, 畠山真吾, 米山徹, 山本勇人, 米山高弘, 橋本安弘, 大山力, 中路重之, 三浦佑規

泌尿器外科 35 ( 臨増 ) 838 - 838 2022.7

骨転移を有する去勢抵抗性前立腺癌に対する塩化ラジウムの治療成績多施設共同研究

佐々木大地, 畠山真吾, 川口英夫, 石橋祐介, 日下歩, 野呂大輔, 田中壽和, 伊藤弘之, 山本勇人, 米山高弘, 橋本安弘, 青木昌彦, 大山力

泌尿器外科 35 ( 臨増 ) 820 - 820 2022.7

転移性腎細胞癌に対するニボルマブ・イピリムマブ併用療法の使用成績

尾崎魁, 鈴木裕一朗, 畠山真吾, 沼倉一幸, 田中壽和, 得居範子, 伊藤弘之, 野呂大輔, 吉川和暁, 米山高弘, 橋本安弘, 羽渕友則, 大山力

泌尿器外科 35 ( 臨増 ) 826 - 826 2022.7

腎結石形成に関与する糖鎖変異オステオポンチンの探索

阿南剛, 米山徹, 廣瀬卓男, 畠山真吾, 森建文, 大山力, 佐藤信

日本尿路結石症学会誌 21 ( 1 ) 49 - 49 2022.7

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy.

Iwamura H, Hatakeyama S, Narita T, Ozaki Y, Konishi S, Horiguchi H, Kodama H, Kojima Y, Fujita N, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Scientific reports 12 ( 1 ) 9675 2022.6

【デジタル革命が導く遠隔医療とAI】Deep learningによる転移性前立腺がんのCRPC進展予測とその問題点

畠山真吾, 米山徹, 岡本哲平, 成田拓磨, 岩村大径, 山本勇人, 米山高弘, 橋本安弘, 大山力

泌尿器科 15 ( 6 ) 646 - 652 2022.6

Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis.

Yanagisawa T, Kimura T, Hata K, Narita S, Hatakeyama S, Mori K, Sano T, Otsuka T, Iwamoto Y, Enei Y, Nakazono M, Sakanaka K, Iwatani K, Matsukawa A, Atsuta M, Nishikawa H, Tsuzuki S, Miki J, Habuchi T, Ohyama C, Shariat SF, Egawa S

World journal of urology 2022.5

Renal metastasis of ovarian granulosa cell tumor.

Togashi K, Yoneyama T, Sutoh Yoneyama M, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Futagami M, Ohyama C

IJU case reports 5 ( 3 ) 186 - 190 2022.5

ロボット支援前立腺全摘術後患者におけるフレイルとQOLおよび下部尿路症状の関連性についての検討(FRARP-QL Study)

富樫赳, 畠山真吾, 岩村大径, 小島由太, 岡本哲平, 米山徹, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本老年泌尿器科学会誌 35 ( 1 ) 160 - 160 2022.5

限局性前立腺癌患者に対するロボット支援腹腔鏡下根治的前立腺全摘除術におけるフレイルと術後疼痛との関連

相馬理, 畠山真吾, 百田匡毅, 岡本哲平, 米山徹, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本老年泌尿器科学会誌 35 ( 1 ) 106 - 106 2022.5

腎移植レシピエントに対するコロナワクチン接種後の血清陽性率の検討

濱谷智子, 畠山真吾, 米山徹, 小玉寛健, 藤田雄, 村上礼一, 鳴海俊治, 大山力

日本透析医学会雑誌 55 ( Suppl.1 ) 677 - 677 2022.5

Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients.

Hamaya T, Hatakeyama S, Yoneyama T, Tobisawa Y, Kodama H, Fujita T, Murakami R, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C

Scientific reports 12 ( 1 ) 5876 2022.4

Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8.

Morozumi K, Mitsuzuka K, Narita S, Takahashi M, Kawamura S, Tochigi T, Arai Y, Hoshi S, Shimoda J, Ishidoya S, Okamoto T, Hatakeyama S, Sakurai T, Tsuchiya N, Ohyama C, Habuchi T, Ito A

International journal of urology : official journal of the Japanese Urological Association 29 ( 4 ) 324 - 331 2022.4

Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma.

Ozaki K, Hatakeyama S, Hamaya T, Okita K, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 29 ( 4 ) 362 - 364 2022.4

乳腺葉状腫瘍と酷似する組織を伴った膀胱癌の1例

濱野逸人, 畠山真吾, 米山美穂子, 濱谷智子, 百田匡毅, 成田拓磨, 小島由太, 岩村大径, 岡本哲平, 米山徹, 山本勇人, 米山高弘, 橋本安弘, 黒瀬顕, 大山力

泌尿器外科 35 ( 4 ) 353 - 354 2022.4

術前化学療法抵抗性のSarcomatiod variantを伴う筋層浸潤性膀胱癌に対しペンブロリズマブで病理学的完全奏功した一例

尾崎佑輔, 岡本哲平, 小西栄, 小玉寛健, 堀口裕貴, 岩村大径, 小島由太, 成田拓磨, 飛澤悠葵, 米山徹, 盛和行, 山本勇人, 畠山真吾, 米山高弘, 橋本安弘, 大山力

泌尿器外科 35 ( 4 ) 360 - 360 2022.4

左腎に晩期再発をきたした卵巣顆粒膜細胞腫の一例

富樫赳, 橋本安弘, 堀口裕貴, 小玉寛健, 成田拓磨, 小島由太, 岩村大径, 岡本哲平, 米山徹, 山本勇人, 畠山真吾, 米山高弘, 大山力

泌尿器外科 35 ( 4 ) 355 - 356 2022.4

免疫チェックポイント阻害剤に対してMixed responseを呈し小腸転移を生じた進行性腎癌の一例

小玉寛健, 畠山真吾, 富樫赳, 堀口裕貴, 成田拓磨, 岩村大径, 小島由太, 岡本哲平, 米山徹, 山本勇人, 米山高弘, 橋本安弘, 大山力, 鬼島宏, 後藤慎太郎

泌尿器外科 35 ( 4 ) 356 - 356 2022.4

【泌尿器科の未来を拓く基礎研究】新規ヒアルロン酸分解酵素transmembrane protein2(TMEM2)の機能

山本勇人, 藤田尚紀, 飛澤悠葵, 米山美穂子, 米山徹, 畠山真吾, 大山力

泌尿器科 15 ( 4 ) 375 - 382 2022.4

【泌尿器科の未来を拓く基礎研究】次世代高精度放射線治療分子標的ホウ素中性子捕捉療法の開発

米山徹, 畠山真吾, 米山美穂子, 飛澤悠葵, 野中元裕, 鈴木実, 八戸慎吾, 大山力

泌尿器科 15 ( 4 ) 351 - 359 2022.4

COVID-19流行下における脳死下臓器提供と献腎移植5例の経験

濱谷智子, 畠山真吾, 小玉寛健, 百田匡毅, 濱野逸人, 成田拓磨, 岩村大径, 小島由太, 村澤洋美, 杉山尚樹, 山本勇人, 米山高弘, 橋本安弘, 齋藤久夫, 大山力

泌尿器外科 35 ( 4 ) 355 - 355 2022.4

RS3PE症候群を契機に診断された重複癌(腎癌・前立腺癌)の一例

成田拓磨, 小玉寛健, 堀口裕貴, 岩村大径, 小島由太, 岡本哲平, 山本勇人, 畠山真吾, 米山高弘, 橋本安弘, 大山力

泌尿器外科 35 ( 4 ) 358 - 358 2022.4

Everolimusが著効した類上皮性腎血管筋脂肪腫術後肺転移の1例

小西栄, 橋本安弘, 尾崎佑輔, 堀口裕貴, 小玉寛健, 成田拓磨, 岩村大径, 小島由太, 藤田尚紀, 岡本哲平, 山本勇人, 畠山真吾, 米山高弘, 大山力

泌尿器外科 35 ( 4 ) 360 - 360 2022.4

Impact of body size on skin-related adverse events in advanced prostate cancer treated with apalutamide: A multicenter retrospective study.

Sasaki D, Hatakeyama S, Tanaka T, Okamoto T, Yoneyama T, Ohyama C.

2022.3

Management of bladder cancer in older patients.

Hatakeyama S, Narita S, Okita K, Narita T, Iwamura H, Fujita N, Inokuchi J, Matsui Y, Kitamura H, Ohyama C

Japanese journal of clinical oncology 52 ( 3 ) 203 - 213 2022.3

Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.

Hatano K, Yoneyama T, Hatakeyama S, Tomiyama E, Tsuchiya M, Nishimoto M, Yoshimura K, Miyoshi E, Uemura H, Ohyama C, Nonomura N, Fujita K

British journal of cancer 126 ( 5 ) 764 - 770 2022.3

Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study.

Kato R, Naito S, Numakura K, Hatakeyama S, Koguchi T, Kojima T, Kawasaki Y, Kandori S, Kawamura S, Arai Y, Ito A, Nishiyama H, Kojima Y, Ohyama C, Habuchi T, Tsuchiya N, Obara W

International journal of clinical oncology 27 ( 3 ) 563 - 573 2022.3

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma.

Ozaki K, Hatakeyama S, Tanaka T, Noro D, Tokui N, Horiguchi H, Okuyama Y, Fujita N, Okamoto T, Okamoto A, Suzuki Y, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass 3 ( 2 ) 139 - 145 2022.3

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.

Okuyama Y, Hatakeyama S, Numakura K, Narita T, Tanaka T, Miura Y, Sasaki D, Noro D, Tokui N, Okamoto T, Yamamoto H, Narita S, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C

BJUI compass 3 ( 2 ) 154 - 161 2022.3

Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer.

Miura Y, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Okuyama Y, Kojima Y, Noro D, Tokui N, Okamoto T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass 3 ( 2 ) 146 - 153 2022.3

Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma.

Taoka R, Kobayashi T, Hidaka Y, Abe H, Ito K, Kojima T, Kato M, Kanda S, Hatakeyama S, Matsui Y, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Kamiyama M, Morita S, Ogawa O, Nishiyama H, Kitamura H, Sugimoto M, Japan Urological Oncology Group

Urologic oncology 40 ( 3 ) 107.e1 - 107.e9 2022.3

Effect of advanced glycation end products on nocturia or sleep disorders: A longitudinal study.

Konishi S, Hatakeyama S, Imai A, Okita K, Kido K, Ozaki Y, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass 3 ( 2 ) 162 - 168 2022.3

Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy.

World journal of urology 2022.2

Management of prostate cancer in older patients.

Narita S, Hatakeyama S, Sakamoto S, Kato T, Inokuchi J, Matsui Y, Kitamura H, Nishiyama H, Habuchi T

2022.2

Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Tanaka T, Hatakeyama S, Noro D, Togashi K, Yoneyama T, Ohyama C.

International journal of urology 2022.2

Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study.

Sasaki D, Hatakeyama S, Kawaguchi H, Hatayama Y, Ishibashi Y, Kusaka A, Noro D, Tanaka T, Ito H, Okuyama Y, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Aoki M, Ohyama C

Urologic oncology 40 ( 2 ) 64.e1 - 64.e8 2022.2

Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study.

Fukushi K, Okamoto T, Ozaki Y, Ozaki K, Sasaki D, Miura Y, Okuyama Y, Tanaka Y, Imanishi K, Hatakeyama S, Saitoh F, Ohyama C

Clinical and experimental nephrology 26 ( 2 ) 190 - 197 2022.2

Cohort profile: Alliance for Quality Assessment in Healthcare-Dialysis (AQuAH-D) prospective cohort study of patients on haemodialysis in Japan.

BMJ Open 2022.1

The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan.

Okuyama Y, Okamoto T, Sasaki D, Ozaki K, Songee J, Hatakeyama S, Mikami T, Ohyama C

International urology and nephrology 54 ( 1 ) 9 - 16 2022.1

Editorial Comment to A case of miliary tuberculosis following transurethral surgery and prostate biopsy after intravesical bacillus Calmette-Guerin immunotherapy.

Hatakeyama S, Ohyama C

IJU case reports 5 ( 1 ) 47 - 48 2022.1

CRPCにおけるリキッドバイオプシー糖鎖とcfDNAを用いた検討

畠山真吾, 米山徹, 濱野逸人, 久保田優花, 松本哲平, 成田拓磨, 藤田尚紀, 岡本哲平, 山本勇人, 米山高弘, 橋本安弘, 大山力

泌尿器科 15 ( 1 ) 83 - 91 2022.1

Editorial Comment to Comparative oncological outcomes after radical prostatectomy or external beam radiation therapy plus androgen deprivation therapy in men with clinical T3b prostate cancer

畠山真吾, 大山力

International Journal of Urology - ( 5 ) 420 - 421 2022

腎移植後症例に対するダプロデュスタット12か月投与における有効性と安全性

村上礼一, 日村美玲, 奈川大輝, 金城育代, 藤田雄, 島田美智子, 富田泰史, 畠山真吾, 米山高弘, 橋本安弘, 大山力

移植 57 ( Supplement ) s289_1 - s289_1 2022

Relationship between the cross-sectional area of the lumbar dural sac and lower urinary tract symptoms: A population-based cross-sectional study.

Oyama T, Wada K, Koyama K, Kumagai G, Tanaka S, Asari T, Imai A, Okamoto T, Hatakeyama S, Jung S, Sugimura Y, Ohyama C, Ishibashi Y

PloS one 17 ( 8 ) e0271479 2022

Effect of active anticancer therapy on serologic response to SARS‐CoV‐2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma

畠山真吾, 米山徹, 大山力

International Journal of Urology - ( 7 ) 733 - 739 2022

The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma.

Okita K, Hatakeyama S, Hagiwara K, Suzuki Y, Tanaka T, Noro D, Tokui N, Fujita N, Konishi S, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology 39 ( 12 ) 832.e17 - 832.e23 2021.12

Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.

Yoneyama T, Yamamoto H, Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Narita T, Kodama H, Momota M, Ito H, Narita S, Tsushima F, Mitsuzuka K, Yoneyama T, Hashimoto Y, Duivenvoorden W, Pinthus JH, Kakeda S, Ito A, Tsuchiya N, Habuchi T, Ohyama C

The Prostate 81 ( 16 ) 1411 - 1427 2021.12

Perioperative Outcomes of Robot-Assisted Radical Cystectomy with Intracorporeal Versus Extracorporeal Urinary Diversion.

Teoh JY, Chan EO, Kang SH, Patel MI, Muto S, Yang CK, Hatakeyama S, Chow TS, Mok A, Zhang R, Kijvikai K, Lee LS, Chen H, Ohyama C, Horie S, Chan ES

Annals of surgical oncology 28 ( 13 ) 9209 - 9215 2021.12

External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study.

Okita K, Hatakeyama S, Naito S, Numakura K, Kato R, Koguchi T, Kojima T, Kawasaki Y, Kandori S, Kawamura S, Nishiyama H, Ito A, Kojima Y, Habuchi T, Obara W, Tsuchiya N, Ohyama C

Urologic oncology 39 ( 12 ) 836.e11 - 836.e17 2021.12

内分泌未治療転移性前立腺癌に対するUpfront治療の成績多施設共同研究

田中壽和, 畠山真吾, 野呂大輔, 小玉寛健, 小西栄, 細越正吾, 成田拓磨, 得居範子, 岡本哲平, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会総会 109回 OP10 - 02 2021.12

転移性腎細胞癌に対する一次治療としてニボルマブ+イピリムマブとチロシンキナーゼ阻害剤の比較検討後方視的多施設共同研究

野呂大輔, 畠山真吾, 沼倉一幸, 城戸宏一, 田中壽和, 及川真亮, 細越正吾, 米山高弘, 橋本安弘, 羽渕友則, 大山力

日本泌尿器科学会総会 109回 PP04 - 03 2021.12

転移性腎癌治療に対してニボルマブ-イピリムマブ併用療法(N-I療法)の有効性と安全性の検討

得居範子, 田中壽和, 畠山真吾, 野呂大輔, 細越正吾, 及川真亮, 山本勇人, 伊藤弘之, 米山高弘, 橋本安弘, 川口俊明, 羽渕友則, 大山力

日本泌尿器科学会総会 109回 PP01 - 05 2021.12

イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法

小玉寛健, 米山徹, 田中壽和, 野呂大輔, 飛澤悠葵, 山本勇人, 須藤晋一郎, 畠山真吾, 米山高弘, 橋本安弘, 柿崎育子, 中路重之, 大山力

日本泌尿器科学会総会 109回 AOP07 - 01 2021.12

フレイルと合併症は限局性前立腺癌の治療選択に関与する因子である

小玉寛健, 畠山真吾, 岡本哲平, 米山徹, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会総会 109回 PP33 - 04 2021.12

特集 THEロボット支援手術-ロボット支援腎部分切除術(RAPN)/ロボット支援膀胱全摘除術(RARC)/新たな術式の徹底理解〈特別付録Web動画〉〈RARC〉男性に対するロボット支援膀胱全摘除術(RARC)

畠山真吾, 米山高弘, 大山力

臨床泌尿器科 75 ( 12 ) 878 - 881 2021.11

Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer.

Mizuno K, Sumiyoshi T, Okegawa T, Terada N, Ishitoya S, Miyazaki Y, Kojima T, Katayama H, Fujimoto N, Hatakeyama S, Shiota M, Yoshimura K, Matsui Y, Narita S, Matsumoto H, Kurahashi R, Kanno H, Ito K, Kimura H, Kamiyama Y, Sunada T, Goto T, Kobayashi T, Yamada H, Tsuchiya N, Kamba T, Matsuyama H, Habuchi T, Eto M, Ohyama C, Ito A, Nishiyama H, Okuno H, Kamoto T, Fujimoto A, Ogawa O, Akamatsu S

Clinical cancer research : an official journal of the American Association for Cancer Research 27 ( 22 ) 6164 - 6173 2021.11

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries.

Konishi S, Narita T, Hatakeyama S, Yoneyama T, Yoneyama MS, Tobisawa Y, Noro D, Sato T, Togashi K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Scientific reports 11 ( 1 ) 22103 2021.11

当科におけるロボット支援腹腔鏡下腎部分切除術の治療成績

山本勇人, 小西栄, 小玉寛健, 小島由太, 岩村大径, 岡本哲平, 畠山真吾, 米山高弘, 橋本安弘, 大山力

日本泌尿器内視鏡学会総会 35回 P - 2 2021.11

難治性間質性膀胱炎・膀胱痛症候群患者の1例

久保田優花, 濱野逸人, 米山徹, 山本勇人, 今井篤, 畠山真吾, 米山高弘, 橋本安弘, 大山力

泌尿器外科 34 ( 11 ) 1296 - 1296 2021.11

Whole Body MRIにて病勢評価が可能であった去勢抵抗性前立腺癌(CRPC)の1例

細越正吾, 畠山真吾, 米山徹, 米山高弘, 橋本安弘, 大山力

泌尿器外科 34 ( 11 ) 1288 - 1288 2021.11

Cell-free DNA(cfDNA)を測定した去勢抵抗性前立腺癌(CRPC)の1例

濱野逸人, 畠山真吾, 米山徹, 鈴木裕一朗, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 大山力

泌尿器外科 34 ( 11 ) 1296 - 1296 2021.11

Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era.

Naito S, Kato T, Numakura K, Hatakeyama S, Koguchi T, Kandori S, Kawasaki Y, Adachi H, Kato R, Narita S, Yamamoto H, Ogawa S, Kawamura S, Obara W, Ito A, Nishiyama H, Kojima Y, Ohyama C, Habuchi T, Tsuchiya N

International journal of clinical oncology 26 ( 10 ) 1947 - 1954 2021.10

血清イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法

小玉寛健, 米山徹, 田中壽和, 野呂大輔, 須藤晋一郎, 飛澤悠葵, 山本勇人, 畠山真吾, 米山高弘, 橋本安弘, 柿崎育子, 中路重之, 大山力

日本癌治療学会学術集会抄録集 59回 O18 - 3 2021.10

高リスク前立腺癌に対する前立腺全摘除術におけるリンパ節郭清の意義に関する検討

岩村大径, 畠山真吾, 尾崎佑輔, 小西栄, 堀口裕貴, 小玉寛健, 成田拓麿, 小島由太, 岡本哲平, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本癌治療学会学術集会抄録集 59回 P28 - 6 2021.10

高リスク上部尿路上皮癌への術前化学療法と腫瘍学的転帰の傾向多施設後ろ向き研究

濱谷智子, 畠山真吾, 田中壽和, 久保田優花, 富樫赳, 細越正吾, 藤田尚紀, 日下歩, 得居範子, 岡本哲平, 山本勇人, 米山徹, 米山高弘, 橋本安弘, 大山力

日本癌治療学会学術集会抄録集 59回 O22 - 1 2021.10

【日本発の臨床研究からみた前立腺癌診療】前立腺癌の診断、悪性度評価に関する日本発のPSA糖鎖変異バイオマーカー

米山徹, 金子智典, 彼谷高敏, 米山美穂子, 飛澤悠葵, 畠山真吾, 大山力

Prostate Journal 8 ( 2 ) 194 - 203 2021.10

転移性去勢感受性前立腺癌に対するUpfront治療の成績多施設共同研究

田中壽和, 畠山真吾, 野呂大輔, 小玉寛健, 小西栄, 沖田和貴, 細越正吾, 成田拓磨, 得居範子, 岡本哲平, 山本勇人, 米山高広, 橋本安弘, 齋藤久夫, 大山力

日本癌治療学会学術集会抄録集 59回 O62 - 6 2021.10

Outcomes of axitinib versus sunitinib as first-line therapy to patients with metastatic renal cell carcinoma in the immune-oncology era.

Numakura K, Muto Y, Naito S, Hatakeyama S, Kato R, Koguchi T, Kojima T, Kawasaki Y, Kandori S, Kawamura S, Arai Y, Ito A, Nishiyama H, Kojima Y, Obara W, Ohyama C, Tsuchiya N, Habuchi T

Cancer medicine 10 ( 17 ) 5839 - 5846 2021.9

Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical Prostatectomy.

Matsuda Y, Narita S, Okubo T, Mitsuzuka K, Hatakeyama S, Koizumi A, Koie T, Kawamura S, Tochigi T, Ito A, Oyama C, Arai Y, Habuchi T

Annals of surgical oncology 28 ( 9 ) 5341 - 5348 2021.9

Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.

Narita T, Hatakeyama S, Numakura K, Kobayashi M, Muto Y, Saito M, Narita S, Tanaka T, Noro D, Tokui N, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 28 ( 9 ) 899 - 905 2021.9

Association between female urinary urgency and aponeurotic ptosis: Results from a community-based cross-sectional study in Japan.

Ozaki Y, Okamoto T, Miura Y, Iida K, Uemura N, Sugimura Y, Hatakeyama S, Urushidate S, Ohyama C

Neurourology and urodynamics 40 ( 6 ) 1678 - 1685 2021.8

Editorial Comment from Dr Hatakeyama and Dr Ohyama to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.

Hatakeyama S, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 28 ( 8 ) 820 2021.8

尿路結石形成に関与する糖鎖変異オステオポンチンの検索

阿南剛, 米山徹, 野呂大輔, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 佐藤信, 大山力

日本内分泌学会雑誌 97 ( S.Update ) 47 - 49 2021.7

Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist.

Liu K, Ma Y, Yang Y, Lu J, Zhao J, Du S, Zhang X, Liu C, Del Giudice F, Shiota M, Hatakeyama S, Zhang X, Kang J

Annals of translational medicine 9 ( 14 ) 1173 2021.7

前立腺癌患者におけるフレイルとQOLの関係(FRAQ-PC study)

濱谷智子, 畠山真吾, 大山力, 橋本安弘, 米山高弘, 今井篤, 山本勇人, 米山徹, 岡本哲平, 藤田尚紀, 濱野逸人, 小島由太, 岩村大径, 成田拓磨, 百田匡毅

泌尿器外科 34 ( 臨増 ) 799 - 799 2021.6

腎臓結石形成に関与する糖鎖変異オステオポンチンの同定

阿南剛, 米山徹, 畠山真吾, 米山高弘, 橋本安弘, 佐藤信, 大山力

日本腎臓学会誌 63 ( 4 ) 447 - 447 2021.6

前立腺癌患者の治療選択とG8スコアの関連性についての検討

富樫赳, 畠山真吾, 百田匡毅, 相馬理, 田中壽和, 濱野逸人, 藤田尚紀, 岡本哲平, 米山徹, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 大山力

泌尿器外科 34 ( 臨増 ) 799 - 799 2021.6

Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.

Okamoto T, Noro D, Hatakeyama S, Narita S, Mitsuzuka K, Sakurai T, Kawamura S, Hoshi S, Shimoda J, Tanaka T, Kawaguchi T, Ishidoya S, Ito A, Tsuchiya N, Habuchi T, Ohyama C

BMC cancer 21 ( 1 ) 605 2021.5

ヌーナン症候群患者に施行した献腎移植の一例

小玉寛健, 畠山真吾, 村澤洋美, 杉山尚樹, 岡本亜希子, 山本勇人, 北原竜次, 米山高弘, 橋本安弘, 齋藤久夫, 大山力

日本透析医学会雑誌 54 ( Suppl.1 ) 463 - 463 2021.5

Narrative review of urinary glycan biomarkers in prostate cancer.

Hatakeyama S, Yoneyama T, Tobisawa Y, Yamamoto H, Ohyama C.

Transl Androl Urol. 2021.4

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama

Urologic oncology 39 ( 4 ) 238.e9 - 238.e17 2021.4

Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in Japan.

Yumina Muto, Shintaro Narita, Shingo Hatakeyama, Shinya Maita, Shuji Chiba, Kyohei Kubo, Yuu Aoyama, Ryuichi Ito, Yoshiko Takahashi, Shuhei Takahashi, Kumiko Nakamura, Naoko Honma, Hiromi Sato, Atsushi Koizumi, Ryoma Igarashi, Katsumi Okane, Toshiya Ishida, Yohei Horikawa, Teruaki Kumazawa, Susumu Akihama, Jiro Shimoda, Takehiro Suzuki, Chikara Ohyama, Tomonori Habuchi

Medical oncology (Northwood, London, England) 38 ( 4 ) 37 - 37 2021.3

Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.

Yuka Kubota, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Itsuto Hamano, Sakae Konishi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

World journal of urology 2021.3

Editorial Comment to Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi-institutional Japan-wide database.

Shingo Hatakeyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 2021.3

Altered gut microbiome associated with overactive bladder and daily urinary urgency.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology 39 ( 3 ) 847 - 853 2021.3

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).

Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Translational andrology and urology 10 ( 3 ) 1143 - 1151 2021.3

ロボット支援腹腔鏡下膀胱全摘除術～現状の課題と今後の方向性～当科におけるRARC+U字回腸新膀胱造設術の成績

米山高弘, 富樫赳, 堀口裕貴, 小玉寛健, 成田拓麿, 岩村大径, 小島由太, 岡本哲平, 山本勇人, 畠山真吾, 橋本安弘, 大山力

日本内視鏡外科学会雑誌 25 ( 7 ) SY16 - 6 2021.3

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study

Tomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, Yuka Kubota, Kyo Togashi, Shogo Hosogoe, Naoki Fujita, Ayumu Kusaka, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJU International 128 ( 4 ) 468 - 476 2021.2

Editorial Comment from Dr Hatakeyama and Dr Ohyama to Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma.

Shingo Hatakeyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 2021.2

N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.

Hirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, Daisuke Noro, Yuki Tobisawa, Hayato Yamamoto, Shinichiro Suto, Shingo Hatakeyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuko Kakizaki, Shigeyuki Nakaji, Chikara Ohyama

Cancer medicine 10 ( 4 ) 1297 - 1313 2021.2

献腎移植を施行したヌーナン症候群の一例

小玉寛健, 畠山真吾, 村澤洋美, 杉山尚樹, 岡本亜希子, 山本勇人, 北原竜次, 米山高弘, 橋本安弘, 齋藤久夫, 大山力

日本臨床腎移植学会プログラム・抄録集 54回 132 - 132 2021.2

血管内皮細胞を標的としたがん特異的療法の開発

畠山真吾, 米山徹, 大山力

細胞 53 ( 2 ) 99 - 103 2021.2

Correction to: Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.

Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, Suzuki M, Hachinohe S, Ishiyama S, Nonaka M, Fukuda MN, Ohyama C

BMC cancer 21 ( 1 ) 105 2021.1

B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.

Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N Fukuda, Chikara Ohyama

BMC cancer 21 ( 1 ) 72 - 72 2021.1

Tumor vasculature-targeted <sup>10</sup>B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.

Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, Suzuki M, Hachinohe S, Ishiyama S, Nonaka M, Fukuda MN, Ohyama C

BMC cancer 21 ( 1 ) 72 2021.1

Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis.

Takuma Narita, Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Jiro Shimoda, Toshiaki Kawaguchi, Shigeto Ishidoya, Koji Mitsuzuka, Yoichi Arai, Akihiro Ito, Norihiko Tsuchiya, Tomonori Habuchi, Chikara Ohyama

Translational andrology and urology 10 ( 1 ) 417 - 425 2021.1

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology 26 ( 1 ) 199 - 206 2021.1

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.

Koichi Kido, Shingo Hatakeyama, Kazuyuki Numakura, Toshikazu Tanaka, Masaaki Oikawa, Daisuke Noro, Shogo Hosogoe, Shintaro Narita, Takamitsu Inoue, Takahiro Yoneyama, Hiroyuki Ito, Shoji Nishimura, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

International journal of clinical oncology 26 ( 1 ) 154 - 162 2021.1

Response to Re: Geriatric 8 screening of frailty in patients with prostate cancer.

Shingo Hatakeyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 27 ( 12 ) 1162 - 1163 2021.1

Prognosis of metastatic castration-resistant prostate cancer in the era of the second-generation androgen receptor-targeted agents: A retrospective multicenter study.

Hiromichi Iwamura, Shingo Hatakeyama, Shintaro Narita, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 28 ( 1 ) 125 - 127 2021.1

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 39 ( 3 ) 194.e9 - 194.e16 2021.1

Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Kazutaka Okita, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Teppei Okamoto, Hiromichi Iwamura, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Lower urinary tract symptoms 13 ( 1 ) 56 - 63 2021.1

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologia internationalis 105 ( 3-4 ) 232 - 239 2021

Editorial Comment.

Shingo Hatakeyama, Itsuto Hamano, Chikara Ohyama

The Journal of urology 205 ( 1 ) 107 - 107 2021

Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.

Toshikazu Tanaka, Shingo Hatakeyama, Kazuyuki Numakura, Koichi Kido, Daisuke Noro, Masaaki Oikawa, Shogo Hosogoe, Noriko Tokui, Hayato Yamamoto, Shintaro Narita, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 27 ( 12 ) 1095 - 1100 2021

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology 39 ( 3 ) 192.e7 - 192.e14 2021

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 39 ( 3 ) 191.e9 - 191.e16 2021

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Hirotake Kodama, Shingo Hatakeyama, Masaki Momota, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology 39 ( 3 ) 191.e1 - 191.e8 2021

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 39 ( 1 ) 75.e9 - 75.e16 2021

Geriatric 8 screening of frailty in patients with prostate cancer.

Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 642 - 648 2021

The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Neurourology and urodynamics 39 ( 5 ) 1567 - 1575 2021

Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.

Kazutaka Okita, Shingo Hatakeyama, Masaki Momota, Osamu Soma, Itsuto Hamano, Toshikazu Tanaka, Hiromichi Iwamura, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 649 - 654 2021

Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function.

Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Transplantation proceedings 52 ( 6 ) 1723 - 1728 2021

Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.

Transplantation proceedings 52 ( 6 ) 1700 - 1704 2021

Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 38 ( 10 ) 795.e9 - 795.e17 2021

Editorial Comment to Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in Japan.

Shingo Hatakeyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 27 ( 6 ) 565 - 566 2021

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Koichi Kido, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 38 ( 8 ) 684.e17 - 684.e24 2021

Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology 38 ( 8 ) 684.e1 - 684.e8 2021

RARCと回腸を利用した尿路変向術

米山高弘, 富樫赳, 堀口裕貴, 小玉寛健, 成田拓磨, 岩村大径, 小島由太, 岡本哲平, 山本勇人, 畠山真吾, 橋本安弘, 大山力

Japanese Journal of Endourology 34 ( 1 ) 24 - 32 2021

Efficacy of one-surgeon basketing technique for stone extraction during flexible ureteroscopy for urolithiasis.

Anan G, Hattori K, Hatakeyama S, Ohyama C, Sato M

Arab journal of urology 19 ( 4 ) 447 - 453 2021

Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab

Takashi Kobayashi, Katsuhiro Ito, Takahiro Kojima, Minoru Kato, Souhei Kanda, Shingo Hatakeyama, Yoshiyuki Matsui, Yuto Matsushita, Sei Naito, Masanobu Shiga, Makito Miyake, Yusuke Muro, Shotaro Nakanishi, Yoichiro Kato, Tadamasa Shibuya, Tetsutaro Hayashi, Hiroaki Yasumoto, Takashi Yoshida, Motohide Uemura, Rikiya Taoka, Manabu Kamiyama, Osamu Ogawa, Hiroshi Kitamura, Hiroyuki Nishiyama

Cancer Science 112 ( 2 ) 760 - 773 2020.12

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology 2020.12

Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective study.

Shingo Hatakeyama, Sei Naito, Kazuyuki Numakura, Renpei Kato, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Shuya Kandori, Sadafumi Kawamura, Eiki Tsushima, Hiroyuki Nishiyama, Akihiro Ito, Yoshiyuki Kojima, Tomonori Habuchi, Wataru Obara, Norihiko Tsuchiya, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 2020.12

ハイリスク前立腺癌に対する術前内分泌化学療法+ロボット支援前立腺全摘術の治療成績

米山高弘, 堀口裕貴, 百田匡毅, 久保田優花, 濱野逸人, 鈴木裕一朗, 米山徹, 山本勇人, 盛和行, 今井篤, 畠山真吾, 橋本安弘, 大山力

日本泌尿器科学会総会 108回 1478 - 1478 2020.12

One-surgeon basketing technique for stone extraction during flexible ureteroscopy for urolithiasis: A comparison between novice and expert surgeons.

Go Anan, Kenji Komatsu, Shingo Hatakeyama, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Masaki Shimbo, Fumiyasu Endo, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Kazunori Hattori, Makoto Sato

International journal of urology : official journal of the Japanese Urological Association 27 ( 12 ) 1072 - 1077 2020.12

去勢抵抗性前立腺癌におけるCell-free DNAのAR amplificationは予後不良因子である

小玉寛健, 畠山真吾, 小西栄, 久保田優花, 相馬理, 松本哲平, 岡本哲平, 米山徹, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会総会 108回 851 - 851 2020.12

腫瘍血管内皮を標的にした新規ホウ素中性子捕捉療法による膀胱癌治療法の開発

畠山真吾, 米山徹, 米山美穂子, 山本勇人, 米山高弘, 橋本安弘, 石山新太郎, 鈴木実, 大山力

日本泌尿器科学会総会 108回 885 - 885 2020.12

尿路結石の発生と予防に対する基礎研究の進歩尿路結石と糖鎖オステオポンチン糖鎖変異の検索

阿南剛, 米山徹, 野呂大輔, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 佐藤信, 大山力

日本泌尿器科学会総会 108回 283 - 283 2020.12

Whole-body MRIの定量化転移性前立腺癌の新たな治療戦略の確立

岩村大径, 伊藤淳, 海法康裕, 小羽田悠貴, 三上穣太郎, 阿南剛, 畠山真吾, 米山高弘, 橋本安弘, 佐藤信, 大山力

日本泌尿器科学会総会 108回 480 - 480 2020.12

転移性去勢抵抗性前立腺癌における原発腫瘍に対する放射線療法の安全性と有効性に関する検討

野呂大輔, 畠山真吾, 富樫赳, 百田匡毅, 藤田尚紀, 飛澤悠葵, 米山徹, 伊藤弘之, 米山高弘, 橋本安弘, 吉川和暁, 真里谷靖, 大山力

日本泌尿器科学会総会 108回 1400 - 1400 2020.12

尿路上皮癌の治療前QOLが予後に与える影響についての検討

村澤洋美, 畠山真吾, Sappaya Suppanuntaroek, 米山徹, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会総会 108回 1703 - 1703 2020.12

前立腺癌患者のフレイルに関するG8スコアの有用性

百田匡毅, 畠山真吾, 相馬理, 田中壽和, 濱野逸人, 藤田尚紀, 岡本哲平, 米山徹, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会総会 108回 1460 - 1460 2020.12

1st-line Axitinib療法におけるIMDCリスク分類の有用性についての検討

小西栄, 畠山真吾, 沼倉一幸, 成田伸太郎, 井上高光, 齋藤満, 米山高弘, 橋本安弘, 吉川和暁, 成田知, 川口俊明, 羽渕友則, 大山力

日本泌尿器科学会総会 108回 1416 - 1416 2020.12

特集泌尿器科医のためのクリニカル・パール-いま伝えたい箴言・格言・アフォリズム〈腫瘍/処置・救急・当直編〉〈腫瘍〉筋層浸潤性膀胱癌のクリニカル・パール

畠山真吾, 米山高弘, 大山力

臨床泌尿器科 74 ( 11 ) 838 - 843 2020.10

Prognosis of metastatic castration‐resistant prostate cancer in the era of the second‐generation androgen receptor‐targeted agents: A retrospective multicenter study

Hiromichi Iwamura, Shingo Hatakeyama, Shintaro Narita, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama

International Journal of Urology 28 ( 1 ) 125 - 127 2020.10

Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis.

Teppei Okamoto, Shingo Hatakeyama, Kyo Togashi, Tomoko Hamaya, Yoshimi Tanaka, Kengo Imanishi, Tooru Takashima, Fumitada Saitoh, Tadashi Suzuki, Chikara Ohyama

Clinical and experimental nephrology 24 ( 10 ) 955 - 962 2020.10

Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C

Clinical genitourinary cancer 18 ( 5 ) e523 - e530 2020.10

転移性腎細胞癌の一次治療におけるニボルマブ・イピリムマブ併用療法とTKIの比較検討

細越正吾, 畠山真吾, 沼倉一幸, 田中壽和, 及川真亮, 野呂大輔, 成田伸太郎, 井上高光, 米山高弘, 伊藤弘之, 西村祥二, 川口俊明, 橋本安弘, 羽渕友則, 大山力

日本癌治療学会学術集会抄録集 58回 P - 289 2020.10

Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus.

Shingo Hatakeyama, Chikara Ohyama

IJU case reports 3 ( 5 ) 183 - 184 2020.9

経尿道的尿管砕石術における1人抽石法の有効性と安全性レーザー使用量を抑え尿路損傷を減らす取り組み

阿南剛, 畠山真吾, 小羽田悠貴, 三上穣太郎, 伊藤淳, 海法康裕, 米山高弘, 橋本安弘, 大山力, 佐藤信

日本レーザー医学会誌 41 ( 3 ) 261 - 261 2020.9

Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes.

Kazuyuki Numakura, Mizuki Kobayashi, Shingo Hatakeyama, Sei Naito, Yohei Horikawa, Toshikazu Tanaka, Sachiko Kamada, Yumina Muto, Ryohei Yamamoto, Atsushi Koizumi, Taketoshi Nara, Sohei Kanda, Mitsuru Saito, Shintaro Narita, Takamitsu Inoue, Naotake Shimoda, Norihiko Tsuchiya, Chikara Ohyama, Tomonori Habuchi

International journal of clinical oncology 25 ( 8 ) 1543 - 1550 2020.8

Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.

Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

IJU case reports 3 ( 4 ) 141 - 144 2020.7

Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Itsuto Hamano, Teppei Okamoto, Koji Mitsuzuka, Akihiro Ito, Norihiko Tsuchiya, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 27 ( 7 ) 610 - 617 2020.7

Survey on attitudes toward brain-dead and living donor transplantation in medical students: a cross-sectional study in Japan.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology 24 ( 7 ) 638 - 645 2020.7

Frailty is a predictor of moderate to severe pain after robot-assisted laparoscopic prostatectomy: A case-control study (FRAP study).

Momota M, Hatakeyama S, Soma O, Hamano I, Fujita N, Okamoto T, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass 1 ( 3 ) 100 - 107 2020.7

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer

Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

IJU Case Reports 3 ( 4 ) 141 - 144 2020.6

尿路結石バイオマーカーとして尿中糖鎖変異オステオポンチン(PolyLacNAc-OPN)の同定

阿南剛, 米山徹, 野呂大輔, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 伊藤淳, 海法康裕, 米山高弘, 橋本安弘, 佐藤信, 大山力

泌尿器科紀要 66 ( 6 ) 180 - 180 2020.6

The impact of microalbuminuria on overactive bladders: Results from a community‐based four‐year longitudinal study in Japan

Neurourology and Urodynamics 39 ( 5 ) 1567 - 1575 2020.5

特集ここが変わった! 膀胱癌診療-新ガイドラインを読み解く StageⅡおよびⅢ膀胱癌の治療

濱野逸人, 畠山真吾, 大山力

臨床泌尿器科 74 ( 5 ) 312 - 315 2020.4

増刊号特集泌尿器科診療の最新スタンダード-平成の常識は令和の非常識腫瘍部位別膀胱癌:手術治療(膀胱全摘除術)

畠山真吾, 米山高弘, 大山力

臨床泌尿器科 74 ( 4 ) 45 - 48 2020.4

Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan‐Japan UTUC Collaboration Cohort

Hao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, Hung Jen Wang, Tohru Yoneyama, Wen Chou Yang, Yao Chi Chuang, Yen Ta Chen, Wei Chin Lee, Yuan Tso Cheng, Chih Hsiung Kang, Po Hui Chiang

International Journal of Urology 27 ( 4 ) 327 - 332 2020.4

特集 Cl-:電解質のクイーン臨床とCl-　尿路変向術に伴う高Cl血症

濱野逸人, 畠山真吾, 大山力

腎と透析 88 ( 3 ) 411 - 414 2020.3

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology 2020.3

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

International urology and nephrology 2020.3

STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.

Kazutaka Okita, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Itsuto Hamano, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 2020.3

Editorial Comment to Incidence and risk factors of postoperative delirium in elderly patients undergoing urological surgery: A multi-institutional prospective study.

Shingo Hatakeyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 27 ( 3 ) 225 - 226 2020.3

Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101.

Motohide Uemura, Yoshihiko Tomita, Hideaki Miyake, Shingo Hatakeyama, Hiro-Omi Kanayama, Kazuyuki Numakura, Toshio Takagi, Tomoyuki Kato, Masatoshi Eto, Wataru Obara, Hirotsugu Uemura, Toni K Choueiri, Robert J Motzer, Yosuke Fujii, Yoichi Kamei, Yoshiko Umeyama, Alessandra di Pietro, Mototsugu Oya

Cancer science 111 ( 3 ) 907 - 923 2020.3

Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort.

Hao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, Hung Jen Wang, Tohru Yoneyama, Wen Chou Yang, Yao Chi Chuang, Yen Ta Chen, Wei Chin Lee, Yuan Tso Cheng, Chih Hsiung Kang, Po Hui Chiang

International journal of urology : official journal of the Japanese Urological Association 2020.2

Serum N-glycan profiling can predict biopsy-proven graft rejection after living kidney transplantation.

Osamu Soma, Shingo Hatakeyama, Tohru Yoneyama, Mitsuru Saito, Hideo Sasaki, Yuki Tobisawa, Daisuke Noro, Yuichiro Suzuki, Masakazu Tanaka, Shin-Ichiro Nishimura, Hiroshi Harada, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Ohyama

Clinical and experimental nephrology 24 ( 2 ) 174 - 184 2020.2

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.

Sappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, Yuka Kubota, Yuichiro Suzuki, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Kazuyuki Mori, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology 25 ( 2 ) 362 - 369 2020.2

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan.

Shintaro Narita, Shingo Hatakeyama, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Atsushi Koizumi, Koji Mitsuzuka, Tatsuo Tochigi, Norihiko Tsuchiya, Chikara Ohyama, Yoichi Arai, Kyoko Nomura, Tomonori Habuchi

International journal of clinical oncology 2020.1

Validation and development of the CHAARTED criteria in patients with hormone-naïve metastatic prostate cancer: A multi-institutional retrospective study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Shintaro Narita, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 27 ( 1 ) 90 - 91 2020.1

ヌーナン症候群患者に施行した献腎移植

小玉寛健, 畠山真吾, 村澤洋美, 杉山尚樹, 岡本亜希子, 山本勇人, 北原竜次, 米山高弘, 橋本安弘, 齋藤久夫, 大山力

移植 55 ( Supplement ) 365_1 - 365_1 2020

当科におけるABO不適合移植の移植成績

濱谷智子, 濱野逸人, 畠山真吾, 藤田雄, 村上礼一, 岡本哲平, 鈴木裕一朗, 山本勇人, 米山徹, 米山高弘, 橋本安弘, 齋藤久夫, 鈴木唯司, 大山力

移植 55 ( Supplement ) 360_1 - 360_1 2020

前立腺がんの過剰診断・過剰治療を回避する糖鎖関連バイオマーカー

米山徹, 飛澤悠葵, 畠山真吾, 大山力

泌尿器科 11(1) 99 - 110 2020

マージナルドナーからの生体腎移植における移植成績ならびにドナー・レシピエント腎機能の検討

濱野逸人, 畠山真吾, 濱谷智子, 百田匡毅, 成田拓磨, 小島由太, 岩村大径, 米山徹, 岡本哲平, 山本勇人, 米山高弘, 橋本安弘, 大山力

移植 55 ( Supplement ) 356_1 - 356_1 2020

ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘術 (RARP) の治療成績

米山高弘, 濱谷智子, 百田匡毅, 濱野逸人, 成田拓磨, 岩村大径, 小島由太, 岡本哲平, 山本勇人, 今井篤, 畠山真吾, 橋本安弘, 大山力

Japanese Journal of Endourology 33 ( 2 ) 325 - 329 2020

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.

Go Anan, Tohru Yoneyama, Daisuke Noro, Yuki Tobisawa, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Takahiro Yoneyama, Yasuhiro Hashimoto, Makoto Sato, Chikara Ohyama

International journal of molecular sciences 21 ( 1 ) 2019.12

Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single-center, open-label, prospective randomized study.

Teppei Okamoto, Shingo Hatakeyama, Sakae Konishi, Kazutaka Okita, Yoshimi Tanaka, Kengo Imanishi, Tooru Takashima, Fumitada Saitoh, Tadashi Suzuki, Chikara Ohyama

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2019.12

The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

The journal of sexual medicine 16 ( 12 ) 1922 - 1929 2019.12

Editorial Comment to Impact of post-void residual urine volume on intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.

Shingo Hatakeyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 26 ( 12 ) 1112 - 1113 2019.12

尿路結石患者における腸内細菌叢の変化についての検討

岡本哲平, 畠山真吾, 今井篤, 米山徹, 山本勇人, 米山高広, 橋本安弘, 大山力, 中路重之

日本尿路結石症学会誌 18 ( 2 ) 106 - 107 2019.12

尿路結石研究における継承と創生-所属・領域を超えて世界へ- オステオポンチン糖鎖変異 PolyLacNAcオステオポンチンの結石バイオマーカーの可能性

阿南剛, 米山徹, 野呂大輔, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 小羽田悠貴, 三上穣太郎, 伊藤淳, 海法康裕, 米山高弘, 橋本安弘, 佐藤信, 大山力

日本尿路結石症学会誌 18 ( 2 ) 24 - 29 2019.12

尿路結石発症を予測するノモグラムの確立

岩村大径, 畠山真吾, 沖田和貴, 今井篤, 田中壽和, 濱野逸人, 藤田尚紀, 飛澤悠葵, 米山徹, 山本勇人, 米山高弘, 橋本安弘, 中路重之, 鈴木唯司, 大山力

日本尿路結石症学会誌 18 ( 2 ) 161 - 162 2019.12

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer.

Teppei Matsumoto, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Shin-Ichiro Nishimura, Chikara Ohyama

Scientific reports 9 ( 1 ) 16761 - 16761 2019.11

Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.

Shintaro Narita, Kyoko Nomura, Shingo Hatakeyama, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Koji Mitsuzuka, Tatsuo Tochigi, Norihiko Tsuchiya, Chikara Ohyama, Yoichi Arai, Kengo Nagashima, Tomonori Habuchi

Cancer medicine 8 ( 15 ) 6566 - 6577 2019.11

Bilateral scrotal mass mimicking testicular cancer: An unusual presentation of sarcoidosis.

Konishi S, Hatakeyama S, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association 26 ( 11 ) 1079 - 1081 2019.11

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.

Osamu Soma, Shingo Hatakeyama, Atsushi Imai, Teppei Matsumoto, Itsuto Hamano, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

Lower urinary tract symptoms 2019.10

Validation and development of the CHAARTED criteria in patients with hormone‐naïve metastatic prostate cancer: A multi‐institutional retrospective study in Japan

Teppei Okamoto, Shingo Hatakeyama, Shintaro Narita, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama

International Journal of Urology 27 ( 1 ) 90 - 91 2019.10

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 26 ( 10 ) 992 - 998 2019.10

第一選択アキシチニブで治療した転移性腎細胞癌患者におけるIMDC予後モデルの検証

小西栄, 畠山真吾, 沼倉一幸, 成田伸太郎, 井上高光, 齋藤満, 得居範子, 山本勇人, 米山高弘, 橋本安弘, 吉川和暁, 成田智, 川口俊明, 羽渕友則, 大山力

日本癌治療学会学術集会抄録集 57回 O45 - 3 2019.10

The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study.

Kazutaka Okita, Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Koji Mitsuzuka, Akihiro Ito, Norihiko Tsuchiya, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama

Clinical genitourinary cancer 2019.9

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Itsuto Hamano, Toshikazu Tanaka, Masaki Momota, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Hisao Saitoh, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

Medical oncology (Northwood, London, England) 36 ( 10 ) 88 - 88 2019.9

医学生における臓器提供への意識 6年間700名のアンケート結果から分かる傾向について

濱野逸人, 畠山真吾, 日下歩, 村澤洋美, 岡本亜希子, 北原竜次, 米山高弘, 橋本安弘, 齋藤久夫, 鈴木唯司, 大山力

移植 54 ( 総会臨時 ) 286 - 286 2019.9

弘前大学腎移植チームによる腎移植の成績

米山高弘, 鈴木裕一朗, 米山徹, 盛和行, 山本勇人, 藤田雄, 今井篤, 村上礼一, 畠山真吾, 橋本安弘, 斉藤久夫, 中村典雄, 鳴海俊治, 鈴木唯司, 大山力

移植 54 ( 総会臨時 ) 327 - 327 2019.9

Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer.

Scientific reports 9 ( 1 ) 12071 - 12071 2019.8

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Tohru Yoneyama, Yuki Tobisawa, Tomonori Kaneko, Takatoshi Kaya, Shingo Hatakeyama, Kazuyuki Mori, Mihoko Sutoh Yoneyama, Teppei Okubo, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Yasuhiro Hashimoto, Akihiro Ito, Takuya Koie, Yoshihiko Suda, Robert A Gardiner, Chikara Ohyama

Cancer science 110 ( 8 ) 2573 - 2589 2019.8

Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer.

Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

IJU case reports 2 ( 4 ) 236 - 239 2019.7

癌性糖鎖変異S2.3PSA検査の前立腺癌診断能および悪性度予測マーカーとしての多施設後ろ向き検討

米山徹, 石川友一, 飛澤悠葵, 畠山真吾, 成田伸太郎, 三塚浩二, 橋本安弘, 古家琢也, 羽渕友則, 伊達睦廣, Duivenvoorden Wilhelmina, Pinthus Jehonathan, 大山力

泌尿器外科 32 ( 臨増 ) 757 - 757 2019.6

筋層浸潤膀胱癌に対する術前化学療法の抗腫瘍効果

阿南剛, 畠山真吾, 藤田尚紀, 岩村大径, 米山高弘, 橋本安弘, 古家琢也, 伊藤弘之, 吉川和暁, 川口俊明, 佐藤信, 大山力

泌尿器科紀要 65 ( 6 ) 248 - 249 2019.6

Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer.

Shusuke Akamatsu, Masashi Kubota, Ryuji Uozumi, Shintaro Narita, Masahiro Takahashi, Koji Mitsuzuka, Shingo Hatakeyama, Toshihiko Sakurai, Sadafumi Kawamura, Shigeto Ishidoya, Senji Hoshi, Masanori Ishida, Kei Mizuno, Keiji Ogura, Takayuki Goto, Naoki Terada, Takashi Kobayashi, Toshinari Yamasaki, Takahiro Inoue, Norihiko Tsuchiya, Chikara Ohyama, Yoichi Arai, Tomonori Habuchi, Satoshi Morita, Osamu Ogawa

European urology oncology 2 ( 3 ) 320 - 328 2019.5

Renal cell carcinoma in a lumbar ectopic kidney.

Hamano I, Hatakeyama S, Soma O, Ishibashi Y, Yoneyama T, Yoneyama T, Hashimoto Y, Nishimura S, Koie T, Ohyama C

IJU case reports 2 ( 3 ) 124 - 127 2019.5

75歳以上の高齢者に対するロボット支援前立腺全摘除術の治療成績

米山高弘, 相馬理, 松本哲平, 米山徹, 鈴木裕一朗, 山本勇人, 今井篤, 畠山真吾, 橋本安弘, 大山力

日本老年泌尿器科学会誌 32 ( 1 ) 193 - 193 2019.5

特集ロボット支援手術を極める-よりハイクラスな手技を求めるあなたに〈特別付録Web動画〉〈ロボット支援膀胱全摘除術〉特記すべき手技と工夫

畠山真吾, 米山高弘, 大山力

臨床泌尿器科 73 ( 5 ) 308 - 311 2019.4

上部尿路上皮内癌(CIS)に対するbacillus Calmette-Guerin(BCG)療法の治療成績根治的腎尿管全摘術(RNU)との比較

堀口裕貴, 米山高弘, 畠山真吾, 得居範子, 山本勇人, 飛澤悠葵, 米山徹, 橋本安弘, 古家琢也, 吉川和暁, 成田知, 川口俊明, 大山力

日本泌尿器科学会総会 107回 PP3 - 288 2019.4

術前の慢性腎臓病は筋層浸潤膀胱癌・上部尿路上皮癌患者の予後不良因子である

百田匡毅, 畠山真吾, 得居範子, 佐藤天童, 山本勇人, 飛澤悠葵, 米山徹, 米山高弘, 橋本安弘, 古家琢也, 成田知, 川口俊明, 大山力

日本泌尿器科学会総会 107回 AOP - 072 2019.4

血清N結合型糖鎖変異プロファイルは生体腎移植後の拒絶反応の予測因子として有用である

相馬理, 畠山真吾, 米山徹, 米山高弘, 橋本安弘, 佐々木秀郎, 齋藤満, 原田浩, 力石辰也, 石田英樹, 田邉一成, 佐藤滋, 大山力

日本泌尿器科学会総会 107回 OP - 008 2019.4

糖鎖バイオマーカーによる前立腺癌診断と悪性度評価

米山徹, 金子智典, 彼谷高敏, 石川友一, 米山美穂子, 畠山真吾, 成田伸太郎, 大久保鉄平, 三塚浩二, 伊藤明宏, 羽渕友則, 大山力

日本泌尿器科学会総会 107回 EP17 - 3 2019.4

急性陰嚢症鑑別スコアの開発精巣捻転と精巣垂捻転の鑑別は可能か?

小玉寛健, 畠山真吾, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 伊藤弘之, 吉川和暁, 佐々木淳, 高橋伸也, 大山力

日本泌尿器科学会総会 107回 PP2 - 143 2019.4

急性腎障害は敗血症を伴う尿路感染症患者において予後・脳心血管イベント・腎機能悪化のリスク因子である

藤田尚紀, 飛澤悠葵, 米山徹, 山本勇人, 今井篤, 畠山真吾, 米山高弘, 伊藤弘之, 橋本安弘, 吉川和暁, 大山力

日本泌尿器科学会総会 107回 AOP - 040 2019.4

初回生検時の血清S2,3PSA検査によるActive surveillance適格症例およびClinical significant症例の検出に関する多施設後ろ向き検討

米山徹, 石川友一, 飛澤悠葵, 畠山真吾, 成田伸太郎, 三塚浩二, 橋本安弘, 伊藤明宏, 羽渕友則, 伊達睦廣, Duivenvoorden Wilhelmina, Pinthus Jehonathan H., 大山力

日本泌尿器科学会総会 107回 OP - 515 2019.4

初回生検時の血清LacdiNAc-PSA glycoisomer検査によるActive surveillance適格症例およびClinical significant症例の検出に関する多施設後ろ向き検討

米山徹, 飛澤悠葵, 金子智典, 彼谷高敏, 畠山真吾, 三塚浩二, 伊藤明宏, 橋本安弘, 須田美彦, Duivenvoorden Wilhelmina, Pinthus Jehonathan H., Gardiner Frank, 大山力

日本泌尿器科学会総会 107回 OP - 514 2019.4

凍結保存精子を用いた卵細胞内精子注入療法における精液所見の影響精巣腫瘍患者と非精巣腫瘍患者の比較

岩村大径, 濱野逸人, 畠山真吾, 中村理果, 米山徹, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 古家琢也, 横山良仁, 大山力

日本泌尿器科学会総会 107回 AOP - 082 2019.4

下部尿路症状と酸化ストレスの関係最終糖化産物(AGEs)と8-OHdGの比較

松本哲平, 山本勇人, 今井篤, 米山徹, 畠山真吾, 米山高弘, 橋本安弘, 中路重之, 大山力

日本泌尿器科学会総会 107回 AOP - 060 2019.4

ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘除術の治療成績

米山高弘, 沖田和貴, 小西栄, 相馬理, 松本哲平, 藤田尚紀, 米山徹, 盛和行, 山本勇人, 今井篤, 畠山真吾, 橋本安弘, 大山力

日本泌尿器科学会総会 107回 OP - 296 2019.4

BCG生菌耐性細胞株の遺伝子発現を指標としたドラッグリポジショニング(第一報)

盛和行, 米山徹, 山本勇人, 今井篤, 畠山真吾, 米山高弘, 橋本安弘, 大山力

泌尿器外科 32 ( 4 ) 392 - 393 2019.4

尿路結石形成に関与する尿中オステオポンチンの糖鎖変異

阿南剛, 米山徹, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 米山高弘, 橋本安弘, 古家琢也, 鈴木唯司, 佐藤信, 大山力

日本尿路結石症学会誌 17 ( 2 ) 117 - 119 2019.3

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shunji Narumi, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology 2019.2

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.

Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Toshikazu Tanaka, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 25 ( 9 ) 817 - 824 2019.2

Clinical impact of glomerular basement membrane thickness on post-donation renal function in living donors.

Yuka Kubota, Shingo Hatakeyama, Ikuyo Narita, Michiko Shimada, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 26 ( 2 ) 309 - 311 2019.2

Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer.

Itsuto Hamano, Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Koji Mitsuzuka, Tatsuo Tochigi, Norihiko Tsuchiya, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama

World journal of urology 2019.2

Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.

Teppei Matsumoto, Shingo Hatakeyama, Takuma Narita, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 2019.1

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.

Kazutaka Okita, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

Clinical genitourinary cancer 2019.1

MIBGシンチ陽性であった副腎癌の1例

得居範子, 日下歩, 細越正吾, 山本勇人, 今井篤, 畠山真吾, 米山高弘, 橋本安弘, 古家琢也, 大山力

泌尿器外科 32 ( 1 ) 94 - 94 2019.1

Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer.

Hirotake Kodama, Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Takuma Narita, Hiromi Sato, Koji Mitsuzuka, Tatsuo Tochigi, Norihiko Tsuchiya, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama

Clinical genitourinary cancer 17 ( 6 ) e1091 - e1098 2019

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Sakae Konishi, Shingo Hatakeyama, Kazuyuki Numakura, Shintaro Narita, Takamitsu Inoue, Mitsuru Saito, Noriko Tokui, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

Clinical genitourinary cancer 17 ( 5 ) e1080 - e1089 2019

Editorial Comment.

Shingo Hatakeyama, Atsushi Imai, Chikara Ohyama

The Journal of urology 202 ( 2 ) 359 - 360 2019

Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Koji Mitsuzuka, Tatsuo Tochigi, Norihiko Tsuchiya, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama

World journal of urology 2018.12

Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes.

Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hirotaka Nagasaka, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto

The international journal of medical robotics + computer assisted surgery : MRCAS 14 ( 6 ) e1955 - e1955 2018.12

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Kazutaka Okita, Shingo Hatakeyama, Naoki Fujita, Sakae Konishi, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Kazuaki Yoshikawa, Takuya Koie, Chikara Ohyama

Medical oncology (Northwood, London, England) 36 ( 1 ) 7 - 7 2018.11

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

Medical oncology (Northwood, London, England) 36 ( 1 ) 6 - 6 2018.11

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Naoki Fujita, Takuya Koie, Yasuhiro Hashimoto, Takuma Narita, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Kazuhisa Hagiwara, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Chikara Ohyama

International urology and nephrology 50 ( 11 ) 1999 - 2005 2018.11

Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Teppei Okamoto, Shingo Hatakeyama, Yoshimi Tanaka, Kengo Imanishi, Tooru Takashima, Fumitada Saitoh, Takuya Koie, Tadashi Suzuki, Chikara Ohyama

Clinical and experimental nephrology 22 ( 5 ) 1174 - 1181 2018.10

Condyloma Acuminata of the Urethra in a Male Renal Transplant Recipient: A Case Report.

I Hamano, S Hatakeyama, H Yamamoto, T Fujita, R Murakami, M Shimada, A Imai, T Yoneyama, T Yoneyama, Y Hashimoto, T Koie, S Narumi, H Saitoh, T Suzuki, H Tomita, C Ohyama

Transplantation proceedings 50 ( 8 ) 2553 - 2557 2018.10

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Teppei Matsumoto, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Kazuhisa Hagiwara, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

BJU international 2018.9

Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.

Teppei Okamoto, Chikako Tsutaya, Shingo Hatakeyama, Sakae Konishi, Kazutaka Okita, Yoshimi Tanaka, Kengo Imanishi, Tooru Takashima, Fumitada Saitoh, Tadashi Suzuki, Chikara Ohyama

International urology and nephrology 50 ( 9 ) 1713 - 1720 2018.9

Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.

Hiromichi Iwamura, Shingo Hatakeyama, Makoto Sato, Chikara Ohyama

Medical oncology (Northwood, London, England) 35 ( 6 ) 94 - 94 2018.5

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Koichi Kido, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

European urology focus 2018.5

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Masaki Momota, Shingo Hatakeyama, Hayato Yamamoto, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget 9 ( 33 ) 23047 - 23057 2018.5

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

Oncotarget 9 ( 25 ) 17396 - 17405 2018.4

Partial Cystectomy of Paraganglioma of the Urinary Bladder Before Living Kidney Transplantation: Case Report.

K Kido, S Hatakeyama, I Hamano, H Yamamoto, A Imai, T Yoneyama, Y Hashimoto, T Koie, T Fujita, R Murakami, H Tomita, T Suzuki, S Narumi, C Ohyama

Transplantation proceedings 50 ( 3 ) 898 - 901 2018.4

The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis.

Teppei Okamoto, Shingo Hatakeyama, Hirotake Kodama, Hirotaka Horiguchi, Yuka Kubota, Koichi Kido, Masaki Momota, Shogo Hosogoe, Yoshimi Tanaka, Tooru Takashima, Fumitada Saitoh, Tadashi Suzuki, Chikara Ohyama

BMC nephrology 19 ( 1 ) 71 - 71 2018.3

The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

Masaki Momota, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

European urology focus 2018.3

Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.

Hirotaka Horiguchi, Takahiro Yoneyama, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England) 35 ( 4 ) 41 - 41 2018.2

Preoperative chronic kidney disease to predict oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Shingo Hatakeyama, Itsuto Hamano, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama

Journal of Clinical Oncology 36 ( 6 ) 427 - 427 2018.2

Significance of serum buttyrylcholinesterase level before chemotherapy as an independent predictor of overall survival in patients with metastatic upper-tract urothelial cancer.

Takahiro Yoneyama, Hirotake Kodama, Shogo Hosogoe, Ayumu Kusaka, Noriko Tokui, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Journal of Clinical Oncology 36 486 2018.2

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: A multicenter study.

Shingo Hatakeyama, Yuka Kubota, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Journal of Clinical Oncology 36 429 2018.2

Effect of detecting asymptomatic recurrence after radical cystectomy on prognosis in patients with muscle invasive bladder cancer.

Shingo Hatakeyama, Ayumu Kusaka, Hirotake Kodama, Noriko Tokui, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Journal of Clinical Oncology 36 428 2018.2

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Shingo Hatakeyama, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Journal of Clinical Oncology 36 430 2018.2

Correlation of MECA-79-positive high endothelial venule density with clinical outcomes in upper tract urothelial carcinoma patients treated with radical nephroureterectomy.

Yasuhiro Hashimoto, Hayato Yamamoto, Tohru Yoneyama, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama,

Journal of Clinical Oncology 36 ( 6 ) 417 2018.2

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

International journal of clinical oncology 2018.2

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.

Hirotaka Horiguchi, Shingo Hatakeyama, Go Anan, Yuka Kubota, Hirotake Kodama, Masaki Momota, Koichi Kido, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget 9 ( 9 ) 8746 - 8755 2018.2

Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.

Daisuke Noro, Takuya Koie, Yasuhiro Hashimoto, Toshikazu Tanaka, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Shingo Hatakeyama, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

Japanese journal of clinical oncology 48 ( 2 ) 184 - 189 2018.2

Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.

Yoshimi Tanaka, Shingo Hatakeyama, Shogo Hosogoe, Toshikazu Tanaka, Itsuto Hamano, Ayumu Kusaka, Hiromich Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology 23 ( 1 ) 134 - 141 2018.2

Slow Progression of Aortic Calcification Is a Potential Benefit of Pre-emptive Kidney Transplantation.

H Mursawa, S Hatakeyama, H Yamamoto, Y Tanaka, O Soma, T Matsumoto, T Yoneyama, Y Hashimoto, T Koie, T Fujita, R Murakami, H Saitoh, T Suzuki, S Narumi, C Ohyama

Transplantation proceedings 50 ( 1 ) 145 - 149 2018

A Case of Fibrous Pseudotumor in the Scrotum: Challenge for Diagnosis and Testicular Preservation

Hirotake Kodama,1 Shingo Hatakeyama,1 Teppei Matsumoto,1 Toshikazu Tanaka,1 Hirotaka Horiguchi,1 Yuka Kubota,1 Hayato Yamamoto,1 Atsushi Imai,2 Takahiro Yoneyama,1 Yasuhiro Hashimoto,2 Takuya Koie,1 and Chikara Ohyama1,2

Case Reports in Urology 2018

Onco-testicular sperm extraction (Onco-TESE) from a single testis with metachronous bilateral testicular cancer: a case report.

Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Hiroko Seino, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama

Basic and clinical andrology 28 1 - 1 2018

Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.

Teppei Okamoto, Shingo Hatakeyama, Shogo Hosogoe, Yoshimi Tanaka, Kengo Imanishi, Toru Takashima, Fumitada Saitoh, Tadashi Suzuki, Chikara Ohyama

PloS one 13 ( 7 ) e0199160 - e0199160 2018

Development of high sensitive LacdiNAc-PSA immunoassay system with surface plasmon field- enhanced fluorescence spectroscopy (SPFS)

Kaneko Tomonori, Kaya Takatoshi, Yoneyama Tohru, Tobisawa Yuki, Hatakeyama Shingo, Hashimoto Yasuhiro, Koie Takuya, Ohyama Chikara, Suda Yoshihiko

Japan Journal of Molecular Tumor Marker Research 33 ( 0 ) 19 - 20 2018

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Shizuka Kurauchi, Ippei Takahashi, Chikara Ohyama

International journal of molecular sciences 18 ( 12 ) 2017.12

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.

Naoki Fujita, Takuya Koie, Chikara Ohyama, Yoshimi Tanaka, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Yasuhiro Hashimoto

International journal of clinical oncology 22 ( 6 ) 1087 - 1093 2017.12

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.

Yuka Kubota, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hiromichi Iwamura, Jotaro Mikami, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget 8 ( 60 ) 101500 - 101508 2017.11

Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.

Toshikazu Tanaka, Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Atsushi Imai, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Tohru Yoneyama, Hirotaka Horiguchi, Hirotake Kodama, Takahiro Yoneyama

Japanese journal of clinical oncology 47 ( 11 ) 1078 - 1082 2017.11

Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.

Teppei Matsumoto, Shingo Hatakeyama, Teppei Ookubo, Koji Mitsuzuka, Shintaro Narita, Takamitsu Inoue, Shinichi Yamashita, Takuma Narita, Takuya Koie, Sadafumi Kawamura, Tatsuo Tochigi, Norihiko Tsuchiya, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

Medical oncology (Northwood, London, England) 34 ( 12 ) 190 - 190 2017.10

Opacity of big toenail predicts poor prognosis in patients with end-stage renal disease on hemodialysis.

Osamu Soma, Shingo Hatakeyama, Teppei Matsumoto, Toshikazu Tanaka, Yoshimi Tanaka, Shogo Hosogoe, Hirotake Kodama, Hirotaka Horiguchi, Yuka Kubota, Koichi Kido, Masaki Momota, Go Anan, Ikuyo Narita, Ryuji Kitahara, Hisao Saitoh, Tadashi Suzuki, Chikara Ohyama

Clinical and experimental nephrology 2017.10

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.

Go Anan, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Toshikazu Tanaka, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget 8 ( 49 ) 86130 - 86142 2017.10

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Hirotake Kodama, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Go Anan, Ken Fukushi, Takuma Narita, Toshikazu Tanaka, Yuka Kubota, Hirotaka Horiguchi, Masaki Momota, Koichi Kido, Teppei Matsumoto, Osamu Soma, Itsuto Hamano, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget 8 ( 47 ) 83183 - 83194 2017.10

The role of LIM and SH3 protein-1 in bladder cancer metastasis.

Misaki Sato, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Tomihisa Funyu, Tadashi Suzuki, Chikara Ohyama, Shigeru Tsuboi

Oncology letters 14 ( 4 ) 4829 - 4834 2017.10

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamurau, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget 8 ( 37 ) 61404 - 61414 2017.9

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget 8 ( 39 ) 65492 - 65505 2017.9

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Takuma Narita, Shingo Hatakeyama, Takuya Koie, Shogo Hosogoe, Teppei Matsumoto, Osamu Soma, Hayato Yamamoto, Tohru Yoneyama, Yuki Tobisawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology 17 ( 1 ) 72 - 72 2017.8

Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.

Daisuke Noro, Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Hideo Sasaki, Mitsuru Saito, Hiroshi Harada, Tatsuya Chikaraishi, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Ohyama

International journal of molecular sciences 18 ( 8 ) 2017.8

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Yoshimi Tanaka, Kazuhisa Hagiwara, Hideaki Hirai, Satoko Morohashi, Hiroshi Kijima, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Oncotarget 8 ( 30 ) 49749 - 49756 2017.7

Fertility preservation of patients with testicular cancer.

Itsuto Hamano, Shingo Hatakeyama, Chikara Ohyama

Reproductive medicine and biology 16 ( 3 ) 240 - 251 2017.7

Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy.

Daisuke Noro, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England) 34 ( 6 ) 117 - 117 2017.6

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England) 34 ( 5 ) 90 - 90 2017.5

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

European urology focus 2017.4

Clinical relevance of aortic calcification in urolithiasis patients.

Toshikazu Tanaka, Shingo Hatakeyama, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology 17 ( 1 ) 25 - 25 2017.4

Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.

Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Shintaro Narita, Shinichi Yamashita, Koji Mitsuzuka, Toshihiko Sakurai, Sadafumi Kawamura, Tatsuo Tochigi, Ippei Takahashi, Shigeyuki Nakaji, Yuki Tobisawa, Hayato Yamamoto, Takuya Koie, Norihiko Tsuchiya, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

Cancer medicine 6 ( 4 ) 739 - 748 2017.4

Surgical treatment of bladder cancer in the geriatric patients.

Koie T, Hatakeyama S, Ohyama C

Nihon rinsho. Japanese journal of clinical medicine 75 ( 4 ) 611 - 614 2017.4

An inconvenient truth: at least three prostate-specific antigen-based screening cycles are needed to reduce subsequent prostate cancer incidence

Hiromichi Iwamura, Takuma Narita, Shingo Hatakeyama

Journal of Xiangya Medicine 2017.3

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 2017.3

An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.

Tomokazu Ishikawa, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Tatsuo Kurosawa, Kenji Nakamura, Shintaro Narita, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Yasuhiro Hashimoto, Takuya Koie, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

International journal of molecular sciences 18 ( 2 ) 2017.2

Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.

Kazuhisa Hagiwara, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Yuki Tobisawa, Tohru Yoneyama

International urology and nephrology 2017.2

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.

Ken Fukushi, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Osamu Soma, Teppei Matsumoto, Itsuto Hamano, Takuma Narita, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology 17 ( 1 ) 13 - 13 2017.2

The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.

Hiromi Murasawa, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi

International journal of clinical oncology 22 ( 1 ) 159 - 165 2017.2

Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.

Kazuhisa Hagiwara, Yuki Tobisawa, Takatoshi Kaya, Tomonori Kaneko, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Yoshihiko Suda, Chikara Ohyama, Tohru Yoneyama

International journal of molecular sciences 18 ( 2 ) 2017.1

The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.

Takuma Narita, Takuya Koie, Teppei Ookubo, Koji Mitsuzuka, Shintaro Narita, Hayato Yamamoto, Takamitsu Inoue, Shingo Hatakeyama, Sadafumi Kawamura, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

Medical oncology (Northwood, London, England) 34 ( 1 ) 1 - 1 2017.1

Solitary Fibrous Tumor of the Prostate Which Was Initially Misdiagnosed as Prostate Cancer.

Soma Osamu, Hiromi Murasawa, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Case reports in urology 2017 3594914 - 3594914 2017

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Yoshimi Tanaka, Shingo Hatakeyama, Toshikazu Tanaka, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

PloS one 12 ( 7 ) e0182136 - e0182136 2017

〈一般演題抄録〉血液透析患者 (HDP) における血中および毛髪中濃度からみた微量金属量の考察

山谷金光, 坪井滋, 蔦谷知佳子, 米山美穂子, 佐藤美沙季, 齋藤久夫, 畠山真吾, 大山力, 舟生富寿

弘前医学 67 ( 2-4 ) 187 2017

A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I.

Mihoko Sutoh Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Misaki Sato, Kiyoshi Tone, Yota Tatara, Ikuko Kakizaki, Tomihisa Funyu, Minoru Fukuda, Senji Hoshi, Chikara Ohyama, Shigeru Tsuboi

Journal of biochemistry 2016.12

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Atsushi Yamauchi, Toru Shimazui, Mikinobu Ohtani

Japanese journal of clinical oncology 2016.12

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Osamu Soma, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology 2016.12

Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.

Masaaki Oikawa, Shingo Hatakeyama, Tohru Yoneyma, Yuki Tobisawa, Takuma Narita, Hayato Yamamoto, Yasuhiro Hashimoto, Takuya Koie, Shintaro Narita, Atsushi Sasaki, Norihiko Tsuchiya, Tomonori Habuchi, Ippei Takahashi, Shigeyuki Nakaji, Chikara Ohyama

European urology focus 2016.11

Recent progress and perspectives on prostate cancer biomarkers.

Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Chikara Ohyama

International journal of clinical oncology 2016.10

Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update.

Yoshinobu Kubota, Noboru Nakaigawa,

International journal of urology : official journal of the Japanese Urological Association 23 ( 8 ) 640 - 645 2016.8

Management of High-Risk Prostate Cancer and Left Ectopic Ureter Inserting into Seminal Vesicle with Ipsilateral Hypoplastic Kidney of a Young Patient : A Case Report

Matsumoto Teppei, Koie Takuya, Soma Osamu, Kusaka Ayumu, Hosogoe Shogo, Hamano Itsuto, Imai Atsushi, Hatakeyama Shingo, Yoneyama Takahiro, Hashimoto Yasuhiro, Ohyama Chikara

Hinyokika Kiyo 62 ( 6 ) 329 - 333 2016.6

学会印象記「第31回EAU」印象記

畠山真吾

臨床泌尿器科 70 ( 7 ) 552 - 553 2016.6

[Management of High-Risk Prostate Cancer and Left Ectopic Ureter Inserting into Seminal Vesicle with Ipsilateral Hypoplastic Kidney of a Young Patient : A Case Report].

Teppei Matsumoto, Takuya Koie, Osamu Soma, Ayumu Kusaka, Shogo Hosogoe, Itsuto Hamano, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica 62 ( 6 ) 329 - 333 2016.6

[Postoperative complications and management after radical prostatectomy].

Takuya Koie, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Nihon rinsho. Japanese journal of clinical medicine 74 Suppl 3 456 - 460 2016.5

Safety and Effectiveness of Marginal Donor in Living Kidney Transplantation.

M Oikawa, S Hatakeyama, T Narita, H Yamamoto, S Hosogoe, A Imai, T Yoneyama, Y Hashimoto, T Koie, T Fujita, R Murakami, H Saitoh, T Funyu, S Narumi, C Ohyama

Transplantation proceedings 48 ( 3 ) 701 - 705 2016.4

Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.

Naoki Fujita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Takeshi Nigawara, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association 2016.2

Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.

Tendo Sato, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Yuta Kojima, Jotaro Mikami, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Biochemical and biophysical research communications 470 ( 1 ) 150 - 156 2016.1

[Multimodality therapy for high-risk prostate cancer].

Shingo Hatakeyama, Chikara Ohyama

Nihon rinsho. Japanese journal of clinical medicine 74 ( 1 ) 114 - 119 2016.1

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.

Shingo Hatakeyama, Takuya Koie, Takuma Narita, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

PloS one 11 ( 2 ) e0149544 - e0149544 2016

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.

Itsuto Hamano, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

SpringerPlus 5 ( 1 ) 1917 - 1917 2016

Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study.

Kazuhisa Hagiwara, Takuya Koie, Hiromichi Iwamura, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BioMed research international 2016 4975851 - 4975851 2016

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.

Tendo Sato, Shingo Hatakeyama, Teppei Okamoto, Hayato Yamamoto, Shogo Hosogoe, Yuki Tobisawa, Tohru Yoneyama, Eiji Hashiba, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuyoshi Hirota, Chikara Ohyama

PloS one 11 ( 5 ) e0153961 - e0153961 2016

Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].

Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

PloS one 11 ( 2 ) e0149544 2016

The potential role of blood group antigen-targeting peptide in ABO-incompatible in renal transplantation

69 ( 13 ) 1093 - 1100 2015.12

I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.

Jotaro Mikami, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda

Cancer science 2015.12

Intracorporeal urinary diversion

69 ( 11 ) 924 - 928 2015.10

Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Shogo Hosogoe, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

International urology and nephrology 47 ( 9 ) 1509 - 1514 2015.9

Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.

Takuya Koie, Chikara Ohyama, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Shogo Hosogoe, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

International journal of clinical oncology 2015.7

Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.

Takahiro Yoneyama, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology 2015.5

Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.

Med Oncol. 2015.1

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.

Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

BMC urology 15 32 - 32 2015

Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.

Hiromichi Iwamura, Takuya Koie, Osamu Soma, Teppei Matsumoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology 15 120 - 120 2015

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.

Yuta Kojima, Tohru Yoneyama, Shingo Hatakeyama, Jotaro Mikami, Tendo Sato, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda, Yuki Tobisawa

PloS one 10 ( 9 ) e0138520 - e0138520 2015

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy.

Shogo Hosogoe, Osamu Soma, Teppei Matsumoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Masahiko Aoki

Case reports in urology 2015 839738 - 839738 2015

Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.

Yusuke Ishibashi, Yuki Tobisawa, Shingo Hatakeyama, Tetsu Ohashi, Masakazu Tanaka, Shintaro Narita, Takuya Koie, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama, Tohru Yoneyama

The Prostate 74 ( 15 ) 1521 - 1529 2014.11

Reassessment of Prognostic Heterogeneity of pT3 Renal Pelvic Urothelial Carcinoma: Analysis in Terms of Proposed pT3 Subclassification Systems

Jinsung Park, Tomonori Habuchi, Youichi Arai, Chikara Ohyama, Takamitsu Inoue, Shingo Hatakeyama, Seong Soo Jeon, Ghee Young Kwon, Cheol Kwak, Kyung Chul Moon, Choung-Soo Kim, Hanjong Ahn

Journal of Urology 192 ( 4 ) 1064 - 1071 2014.10

A patient experienced acute dyspnea and chest pain at first postoperative walking after a open or laparoscopic surgery

68 ( 9 ) 685 - 687 2014.8

Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Masato Kitayam, Kazuyoshi Hirota

Urologic oncology 32 ( 6 ) 820 - 825 2014.8

Tubulocystic renal cell carcinoma in the left kidney: a case report.

Yusuke Ishibashi, Takuya Koie, Naoki Fujita, Tendo Satoh, Jotaro Mikami, Shingo Hatakeyama, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama

Journal of medical case reports 8 ( 1 ) 265 - 265 2014.7

Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer.

Tohru Yoneyama, Chikara Ohyama, Shingo Hatakeyama, Shintaro Narita, Tomonori Habuchi, Takuya Koie, Kazuyuki Mori, Kazuya I P J Hidari, Maho Yamaguchi, Takashi Suzuki, Yuki Tobisawa

Biochemical and biophysical research communications 448 ( 4 ) 390 - 396 2014.6

Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cells.

Kengo Imanishi, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Hayato Yamamoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Toshiya Nakamura, Chikara Ohyama, Shigeru Tsuboi

Molecular medicine reports 9 ( 6 ) 2159 - 2165 2014.6

Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.

Takahiro Yoneyama, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology 2014.5

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

Medical oncology (Northwood, London, England) 31 ( 5 ) 949 - 949 2014.5

Reassessment of Prognostic Heterogeneity of pT3 Renal Pelvic Urothelial Carcinoma: Analysis in Terms of 3 Proposed pT3 Subclassification Systems.

Jinsung Park, Tomonori Habuchi, Youichi Arai, Chikara Ohyama, Takamitsu Inoue, Shingo Hatakeyama, Seong Soo Jeon, Ghee Young Kwon, Cheol Kwak, Kyung Chul Moon, Choung-Soo Kim, Hanjong Ahn

The Journal of urology 2014.4

増刊号特集前立腺癌の診療ナビゲーション-わかりやすく丁寧に! II　前立腺癌の診断 6.病理とGleason score

畠山真吾, 諸橋聡子, 橋本安弘

臨床泌尿器科 68 ( 4 ) 65 - 69 2014.4

Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis.

Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Tomonori Habuchi, Takamitsu Inoue, Toshiya Nakamura, Tomihisa Funyu, Gerhard Wiche, Chikara Ohyama, Shigeru Tsuboi

European journal of cell biology 93 ( 4 ) 157 - 169 2014.4

Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formation.

Noriko Tokui, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Hayato Yamamoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Toshiya Nakamura, Chikara Ohyama, Shigeru Tsuboi

Molecular medicine reports 9 ( 4 ) 1142 - 1146 2014.4

Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis.

Shingo Hatakeyama, Maho Amano, Yuki Tobisawa, Tohru Yoneyama, Norihiko Tsuchiya, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama

The Journal of urology 191 ( 3 ) 805 - 813 2014.3

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Masahiko Aoki, Yoshihiro Takai

World journal of surgical oncology 12 134 - 134 2014.3

Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy.

Takuya Koie, Chikara Ohyama, Jotaro Mikami, Hiromichi Iwamura, Naoki Fujita, Tendo Sato, Yuta Kojima, Ken Fukushi, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Masato Kitayama, Kazuyoshi Hirota

TheScientificWorldJournal 2014 948305 - 948305 2014.3

Renal cell carcinoma detected by preoperative kidney transplant donor examination: a case report.

T Sato, Takahiro Yoneyama, K Hagiwara, T Narita, D Noro, T Tanaka, Y Tanaka, Y Tobisawa, Tohru Yoneyama, H Yamamoto, A Okamoto, A Imai, S Hatakeyama, Y Hashimoto, T Koie, C Ohyama

Transplantation proceedings 46 ( 2 ) 634 - 636 2014.3

BK virus-associated urothelial carcinoma of a ureter graft in a renal transplant recipient: a case report.

M Oikawa, S Hatakeyama, T Fujita, R Murakami, K Hagiwara, T Narita, D Noro, T Tanaka, Y Tanaka, Y Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Y Hashimoto, T Koie, S Narumi, C Ohyama

Transplantation proceedings 46 ( 2 ) 616 - 619 2014.3

Post-transplant renal function and cardiovascular events are closely associated with the aortic calcification index in renal transplant recipients.

K Imanishi, S Hatakeyama, H Yamamoto, A Okamoto, A Imai, T Yoneyama, Y Hashimoto, T Koie, T Fujita, R Murakami, H Saitoh, T Funyu, S Narumi, C Ohyama

Transplantation proceedings 46 ( 2 ) 484 - 488 2014.3

Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.

S Hatakeyama, T Fujita, R Murakami, Y Suzuki, N Sugiyama, H Yamamoto, A Okamoto, A Imai, Y Tobisawa, T Yoneyama, K Mori, T Yoneyama, Y Hashimoto, T Koie, S Narumi, C Ohyama

Transplantation proceedings 46 ( 2 ) 445 - 448 2014.3

A Case of Malignant Pheochromocytoma Detected during Fertility Treatment.

Kazuhisa Hagiwara, Itsuto Hamano, Ayumu Kusaka, Hiromi Murasawa, Noriko Tokui, Kengo Imanishi, Akiko Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Case reports in urology 2014 646743 - 646743 2014.2

Primary leiomyosarcoma of a horseshoe kidney in a woman with Turner syndrome: a case report.

Toshikazu Tanaka, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

BMC research notes 7 ( 1 ) 491 - 491 2014.1

Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient.

Takuya Narita, Itsuto Hamano, Ayumu Kusaka, Hiromi Murasawa, Noriko Tokui, Kengo Imanishi, Teppei Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Kenichi Hakamada

Case reports in oncology 7 ( 1 ) 233 - 238 2014.1

[Capillary hemangioma in renal hilum; a case report].

Masaaki Oikawa, Shingo Hatakeyama, Itsuto Hamano, Toshikazu Tanaka, Yoshimi Tanaka, Takuma Narita, Daisuke Noro, Kazuhisa Hagiwara, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica 60 ( 1 ) 33 - 37 2014.1

Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer.

Tatsuo Kido, Stephanie Schubert, Shingo Hatakeyama, Chikara Ohyama, Jörg Schmidtke, Yun-Fai Chris Lau

Cell & bioscience 4 ( 1 ) 9 - 9 2014.1

A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.

Hiromichi Iwamura, Shingo Hatakeyama, Yoshimi Tanaka, Toshikazu Tanaka, Noriko Tokui, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuaki Yoshikawa, Chikara Ohyama

BMC research notes 7 64 - 64 2014.1

Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer.

Chikara Ohyama, Shingo Hatakeyama, Takahiro Yoneyama, Takuya Koie

International journal of urology : official journal of the Japanese Urological Association 21 ( 1 ) 3 - 4 2014.1

Capillary Hemangioma in Renal Hilum ; A Case Report

Oikawa Masaaki, Hatakeyama Shingo, Hamano Itsuto, Tanaka Toshikazu, Tanaka Yoshimi, Narita Takuma, Noro Daisuke, Hagiwara Kazuhisa, Ohyama Chikara

Hinyokika Kiyo 60 ( 1 ) 33 - 37 2014.1

Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.

Shingo Hatakeyama, Hiromi Murasawa, Takuma Narita, Masaaki Oikawa, Naoki Fujita, Hiromichi Iwamura, Joutaro Mikami, Yuta Kojima, Tendo Sato, Ken Fukushi, Yusuke Ishibashi, Yasuhiro Hashimoto, Takuya Koie, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama

BMC nephrology 14 222 - 222 2013.12

Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center.

Shingo Hatakeyama, Takahiro Yoneyama, Itsuto Hamano, Hiromi Murasawa, Takuma Narita, Masaaki Oikawa, Kazuhisa Hagiwara, Daisuke Noro, Toshikazu Tanaka, Yoshimi Tanaka, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

BMC urology 13 47 - 47 2013.12

Chromophobe renal cell carcinoma with concomitant sarcomatoid transformation and osseous metaplasia: a case report.

Yoshimi Tanaka, Takuya Koie, Shingo Hatakeyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology 13 72 - 72 2013.12

Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.

Takuya Koie, Chikara Ohyama, Akiko Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto

BMC research notes 6 484 - 484 2013.12

Prognosis of elderly Japanese patients aged ≥80 years undergoing hemodialysis.

Shingo Hatakeyama, Hiromi Murasawa, Itsuto Hamano, Ayumu Kusaka, Takuma Narita, Masaaki Oikawa, Daisuke Noro, Kazuhisa Hagiwara, Hirofumi Ishimura, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama

TheScientificWorldJournal 2013 693514 - 693514 2013.12

Serum N-glycan profiling predicts prognosis in patients undergoing hemodialysis.

Shingo Hatakeyama, Maho Amano, Yuki Tobisawa, Tohru Yoneyama, Megumi Tsushima, Kazuko Hirose, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Shin-Ichiro Nishimura, Chikara Ohyama

TheScientificWorldJournal 2013 268407 - 268407 2013.12

Pathological and oncological outcomes of elderly men with clinically localized prostate cancer.

Koji Mitsuzuka, Takuya Koie, Shintaro Narita, Yasuhiro Kaiho, Takahiro Yoneyama, Norihiko Tsuchiya, Narihiko Kakoi, Sadafumi Kawamura, Tatsuo Tochigi, Chikara Ohyama, Tomonori Habuchi, Yoichi Arai

Japanese journal of clinical oncology 43 ( 12 ) 1238 - 1242 2013.12

Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.

Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Shingo Hatakeyama, Hayato Yamamoto, Takahiro Yoneyama, Noritaka Kamimura

International journal of clinical oncology 18 ( 4 ) 724 - 730 2013.8

[Ureteral endometriosis treated by hormonal therapy : a case report].

Jotaro Mikami, Hayato Yamamoto, Akiko Okamoto, Hirofumi Ishimura, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica 59 ( 7 ) 431 - 434 2013.7

[Local recurrence of pheochromocytoma associated with von hippel-lindau disease 26 years after bilateral adrenalectomy : a case report].

Naoki Fujita, Jotaro Mikami, Hiromi Murasawa, Akiko Okamoto, Atsushi Imai, Shingo Hatakeyama, Hirofumi Ishimura, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Chikara Ohyama, Satoko Morohashi, Hiroshi Kijima

Hinyokika kiyo. Acta urologica Japonica 59 ( 7 ) 427 - 430 2013.7

[Successful Control of Hyper-Cortisolemia Due to ACTH-Producing Thyroid Carcinoid by Laparoscopic Bilateral Adrenalectomy : A Case Report].

Yuta Kojima, Noritaka Kamimura, Hayato Yamamoto, Hiromi Murasawa, Akiko Okamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica 59 ( 7 ) 419 - 422 2013.7

In vivo selection of high-metastatic subline of bladder cancer cell and its characterization.

Naoki Sugiyama, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Hayato Yamamoto, Akiko Okamoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Takamitsu Inoue, Tomonori Habuchi, Chikara Ohyama, Shigeru Tsuboi

Oncology research 20 ( 7 ) 289 - 295 2013.7

Local Recurrence of Pheochromocytoma Associated with von Hippel-Lindau Disease 26 Years after Bilateral Adrenalectomy : A Case Report

Fujita Naoki, Mikami Jotaro, Murasawa Hiromi, Okamoto Akiko, Imai Atsushi, Hatakeyama Shingo, Ishimura Hirofumi, Yoneyama Takahiro, Koie Takuya, Kamimura Noritaka, Ohyama Chikara, Morohashi Satoko, Kijima Hiroshi

Hinyokika Kiyo 59 ( 7 ) 427 - 430 2013.7

Ureteral Endometriosis Treated by Hormonal Therapy : A Case Report

Mikami Jotaro, Yamamoto Hayato, Okamoto Akiko, Ishimura Hirofumi, Imai Atsushi, Hatakeyama Shingo, Yoneyama Takahiro, Hashimoto Yasuhiro, Koie Takuya, Ohyama Chikara

Hinyokika Kiyo 59 ( 7 ) 431 - 434 2013.7

Tumor targeting by a carbohydrate ligand-mimicking peptide.

Shingo Hatakeyama, Toshiaki K Shibata, Yuki Tobisawa, Chikara Ohyama, Kazuhiro Sugihara, Michiko N Fukuda

Methods in molecular biology (Clifton, N.J.) 1022 369 - 386 2013.6

Gene expression changes in venous segment of overflow arteriovenous fistula.

Yasuhiro Hashimoto, Akiko Okamoto, Hisao Saitoh, Shingo Hatakeyama, Takahiro Yoneyama, Takuya Koie, Chikara Ohyama

International journal of nephrology 2013 980923 - 980923 2013.4

[Paget's disease mimicking metastatic prostate cancer on bone scan image : a case report].

Ken Fukushi, Takuya Koie, Hayato Yamamoto, Akiko Okamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica 59 ( 4 ) 247 - 250 2013.4

Paget's Disease Mimicking Metastatic Prostate Cancer on Bone Scan Image : A Case Report

Fukushi Ken, Koie Takuya, Yamamoto Hayato, Okamoto Akiko, Imai Atsushi, Hatakeyama Shingo, Yoneyama Takahiro, Hashimoto Yasuhiro, Ohyama Chikara

Hinyokika Kiyo 59 ( 4 ) 247 - 250 2013.4

[Testicular tumor arising in intra-abdominal testis which was not detected at prior orchidopexy : a case report].

Hiromichi Iwamura, Shingo Hatakeyama, Ken Fukushi, Tendo Sato, Yuta Kojima, Hiromi Murasawa, Hirofumi Ishimura, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Satoko Morobashi, Hiroshi Kijima, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica 59 ( 3 ) 189 - 193 2013.3

Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis.

Norihiko Tsuchiya, Shintaro Narita, Takamitsu Inoue, Mitsuru Saito, Kazuyuki Numakura, Mingguo Huang, Shingo Hatakeyama, Shigeru Satoh, Seiichi Saito, Chikara Ohyama, Yoichi Arai, Osamu Ogawa, Tomonori Habuchi

BMC cancer 13 150 - 150 2013.3

Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma.

Norihiko Tsuchiya, Shintaro Narita, Takamitsu Inoue, Naoko Hasunuma, Kazuyuki Numakura, Yohei Horikawa, Shigeru Satoh, Takeshi Notoya, Naohito Fujishima, Shingo Hatakeyama, Chikara Ohyama, Tomonori Habuchi

Anti-cancer drugs 24 ( 3 ) 310 - 314 2013.3

Testicular Tumor Arising in Intra-Abdominal Testis which was Not Detected at Prior Orchidopexy : A Case Report

Iwamura Hiromichi, Hatakeyama Shingo, Fukushi Ken, Sato Tendo, Kojima Yuta, Murasawa Hiromi, Ishimura Hirofumi, Yoneyama Takahiro, Koie Takuya, Kamimura Noritaka, Morobashi Satoko, Kijima Hiroshi, Ohyama Chikara

Hinyokika Kiyo 59 ( 3 ) 189 - 193 2013.3

Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.

Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Hayato Yamamoto, Kengo Imanishi, Teppei Okamoto, Noriko Tokui, Naoki Sugiyama, Yuichiro Suzuki, Shigemasa Kudo, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Michiko N Fukuda, Chikara Ohyama

Transplantation 95 ( 3 ) 418 - 425 2013.2

Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.

Teppei Okamoto, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Kazuyuki Mori, Hayato Yamamoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Minoru Fukuda, Chikara Ohyama, Shigeru Tsuboi

Molecular medicine reports 7 ( 2 ) 359 - 364 2013.2

Distinct cancer-specific survival in metastatic prostate cancer patients classified by a panel of single nucleotide polymorphisms of cancer-associated genes.

Norihiko Tsuchiya, Shigeyuki Matsui, Shintaro Narita, Tomomi Kamba, Koji Mitsuzuka, Shingo Hatakeyama, Yohei Horikawa, Takamitsu Inoue, Seiichi Saito, Chikara Ohyama, Yoich Arai, Osamu Ogawa, Tomonori Habuchi

Genes & cancer 4 ( 1-2 ) 54 - 60 2013.1

[Adult mature teratoma of the testis: a case report].

Kengo Imanishi, Shingo Hatakeyama, Teppei Okamoto, Yuichiro Suzuki, Naoki Sugiyama, Hayato Yamamoto, Shigemasa Kudo, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica 59 ( 1 ) 57 - 60 2013.1

Adult Mature Teratoma of the Testis : A Case Report

Imanishi Kengo, Hatakeyama Shingo, Okamoto Teppei, Suzuki Yuichiro, Sugiyama Naoki, Yamamoto Hayato, Kudo Shigemasa, Yoneyama Takahiro, Hashimoto Yasuhiro, Koie Takuya, Kamimura Noritaka, Ohyama Chikara

Hinyokika Kiyo 59 ( 1 ) 57 - 60 2013.1

Examination of the carotid artery flow-velocity waveform velocity in hemodialysis patients

Tsutaya Chikako, Tsushima Megumi, Terayama Yuriko, Hatakeyama Shingo, Yamaya Kanemitsu, Saitoh Hisao, Funyu Tomihisa

Nihon Toseki Igakkai Zasshi 46 ( 8 ) 715 - 721 2013

Safety and effectiveness of neoadjuvant luteinizing hormone-releasing hormone agonist plus low-dose estramustine phosphate in high-risk prostate cancer: a prospective single-arm study.

T Koie, C Ohyama, H Yamamoto, S Hatakeyama, T Yoneyama, Y Hashimoto, N Kamimura

Prostate cancer and prostatic diseases 15 ( 4 ) 397 - 401 2012.12

[Metastatic renal tumor from oral floor cancer: a case report].

Yusuke Ishibashi, Shingo Hatakeyama, Teppei Okamoto, Yuichiro Suzuki, Shigemasa Kudo, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Hirotaka Sakaki, Wataru Kobayashi, Hiroto Kimura, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica 58 ( 11 ) 609 - 612 2012.11

Enhancement of mouse sperm motility by trophinin-binding peptide.

Seong Kyu Park, Jiwon Yoon, Ling Wang, Toshiaki K Shibata, Khatereh Motamedchaboki, Kyung Jun Shim, Mun Seog Chang, Seung Ho Lee, Naoaki Tamura, Shingo Hatakeyama, Daita Nadano, Kazuhiro Sugihara, Michiko N Fukuda

Reproductive biology and endocrinology : RB&E 10 101 - 101 2012.11

Metastatic Renal Tumor from Oral Floor Cancer : A Case Report

Ishibashi Yusuke, Hatakeyama Shingo, Okamoto Teppei, Suzuki Yuichiro, Kudo Shigemasa, Yoneyama Takahiro, Koie Takuya, Kamimura Noritaka, Sakaki Hirotaka, Kobayashi Wataru, Kimura Hiroto, Ohyama Chikara

Hinyokika Kiyo 58 ( 11 ) 609 - 612 2012.11

Carbohydrate mimetic peptides as research reagent and therapeutic.

Michiko N Fukuda, Shingo Hatakeyama, Kazuhiro Sugihara

Biological & pharmaceutical bulletin 35 ( 10 ) 1626 - 1632 2012.10

Minimum incision endoscopic radical cystectomy in patients with malignant tumors of the urinary bladder: Clinical and oncological outcomes at a single institution.

Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Kudoh S, Yoneyama T, Hashimoto Y, Kamimura N.

Eur J Surg Oncol. 2012.8

Sarcoidosis of the ureter.

Hashimoto Y, Kudoh S, Yamamoto H, Hatakeyama S, Yoneyama T, Koie T, Kamimura N, Ohyama C.

Urology. 2012.6

MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.

Yuichiro Suzuki, Mihoko Sutoh, Shingo Hatakeyama, Kazuyuki Mori, Hayato Yamamoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Tomonori Habuchi, Yoichi Arai, Minoru Fukuda, Chikara Ohyama, Shigeru Tsuboi

International journal of oncology 40 ( 6 ) 1831 - 1838 2012.6

Skin perfusion pressure is a prognostic factor in hemodialysis patients.

Hatakeyama S, Saito M, Ishigaki K, Yamamoto H, Okamoto A, Ishibashi Y, Murasawa H, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C.

Int J Nephrol. 2012.4

Two opposing roles of O-glycans in tumor metastasis.

Shigeru Tsuboi, Shingo Hatakeyama, Chikara Ohyama, Minoru Fukuda

Trends in molecular medicine 18 ( 4 ) 224 - 232 2012.4

Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.

Inoue T, Matsuura K, Yoshimoto T, Nguyen LT, Tsukamoto Y, Nakada C, Hijiya N, Narimatsu T, Nomura T, Sato F, Nagashima Y, Kashima K, Hatakeyama S, Ohyama C, Numakura K, Habuchi T, Nakagawa M, Seto M, Mimata H, Moriyama M.

Cancer Sci. 2012.3

Adrenal pheochromocytoma with multiple neurofibromatosis on the trunk

Tokui N, Okamoto T, Imanishi K, Sugiyama N, Suzuki Y, Ishimura H, Hatakeyama S, Kudoh S, Yoneyama T, Koie T, Kamimura N, Ohyama C.

Tokui N, Okamoto T, Imanishi K, Sugiyama N, Suzuki Y, Ishimura H, Hatakeyama S, Kudoh S, Yoneyama T, Koie T, Kamimura N, Ohyama C. 2012.1

A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.

Hatakeyama S, Fujita T, Yoneyama T, Yoneyama T, Koie T, Hashimoto Y, Saitoh H, Funyu T, Narumi S, Ohyama C.

Transplant Proc. 2012.1

Kidney transplantation at Hirosaki kidney transplant unit -initial 5-year experience

Narumi Shunji, Murakami Reiichi, Hatakeyama Shingo, Fujita Tadashi, Koie Takuya, Yoneyama Takahiro, Kudoh Shigemasa, Kamimura Noritaka, Mori Kazuyuki, Shimada Michiko, Nakamura Norio, Umehara Minoru, Saitoh Hisao, Okumura Ken, Hakamada Kenichi, Ohyama Chikara

Hirosaki Medical Journal 63 ( 2-4 ) 136 - 142 2012

Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer.

Hashimoto Y, Imanishi K, Tokui N, Okamoto T, Okamoto A, Hatakeyama S, Yoneyama T, Koie T, Kamimura N, Ohyama C.

Int J Clin Oncol. 2011.12

Radical cystectomy with muscle:invasive bladder cancer in male patients

65 ( 13 ) 999 - 1001 2011.12

Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.

Hatakeyama S, Sugihara K, Shibata TK, Nakayama J, Akama TO, Tamura N, Wong SM, Bobkov AA, Takano Y, Ohyama C, Fukuda M, Fukuda MN.

Proc Natl Acad Sci U S A 2011.12

Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis.

Hatakeyama S, Toikawa T, Okamoto A, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Suzuki Y, Sugiyama N, Imai A, Hashimoto Y, Kudo S, Yoneyama T, Koie T, Kamimura N, Saitoh H, Funyu T, Ohyama C.

Int J Nephrol. 2011.10

Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease.

Hatakeyama S, Yamamoto H, Okamoto A, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C.

Int J Nephrol. 2011.10

Clearance and safety of the radiocontrast medium iopamidol in peritoneal dialysis patients.

Hatakeyama S, Abe A, Suzuki T, Hashimoto Y, Koie T, Funyu T, Satoh S, Habuchi T, Ohyama C, and Matsuo S.

Int J Nephrol 2011.10

Minimum Incision Endoscope-Assisted Radical Prostatectomy: Clinical and Oncological Outcomes at a Single Institute

Koie T, Yoneyama Y, Hatakeyama S, Kamimura N, Ohyama C.

Eur J Surg Oncol. 2011.9

Clearance and safety of the radiocontrast medium iopamidol in peritoneal dialysis patients.

Hatakeyama S, Abe A, Suzuki T, Hashimoto Y, Koie T, Funyu T, Satoh S, Habuchi T, Ohyama C, Matsuo S.

Int J Nephrol. 2011.8

Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population

Hasimoto Y, Koie T, Yoneyama Y, Hatakeyama S, Kamimura N, Ohyama C.

J Clin. Oncol. 2011.6

Requirement for FBP17 in invadopodia formation by invasive bladder tumor cells.

Yamamoto H, Sutoh M, Hatakeyama S, Hashimoto Y, Yoneyama T, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S.

J Urol 2011.5

特集こんなときどうする!?-泌尿器科手術のトラブル対処法 IV　開腹手術 ■膀胱の手術 081　放射線性膀胱炎のため膀胱が骨盤壁にへばりついている

古家琢也, 今西賢吾, 畠山真吾, 米山高弘

臨床泌尿器科 65 ( 4 ) 223 - 223 2011.4

Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy

Kamimura N, Hatakeyama S, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Kawaguchi T, Takahashi S, Ohyama C.

Hinyokika Kiyo 2011.2

PP-816 SNPアレイを用いた転移性前立腺癌の生存期間に関与する癌関連遺伝子の探索(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

土谷順彦, 成田伸太郎, 井上高光, 鶴田大, 沼倉一幸, 堀川洋平, 畠山真吾, 大山力, 荒井陽一, 小川修, 斎藤誠一, 松井茂之, 羽渕友則

日本泌尿器科学会雑誌 102 ( 2 ) 540 2011

PP-397 Expression of Aldose Reductase in collecting duct carcinoma is distinct from confusing renal malignancies

The Japanese Journal of Urology 102 ( 2 ) 470 2011

PP-390 ABO血液型抗原をマスクするペプチド配列のスクリーニング(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

米山徹, 畠山真吾, 今西賢吾, 得居範子, 岡本哲平, 杉山尚樹, 鈴木裕一朗, 工藤茂将, 米山高弘, 盛和行, 古家琢也, 神村典孝, 大山力

日本泌尿器科学会雑誌 102 ( 2 ) 468 2011

PP-318 前立腺全摘除術後の下部尿路機能評価 : 1年後の尿失禁の予測因子は何か(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

杉山尚樹, 今西賢吾, 岡本哲平, 得居範子, 鈴木裕一朗, 畠山真吾, 工藤茂将, 米山高弘, 古家琢也, 神村典孝, 大山力

日本泌尿器科学会雑誌 102 ( 2 ) 456 2011

PP-317 住民健診におけるロコモティブシンドロームと男性下部尿路症状との関連性の検討(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

今井篤, 橋本安弘, 佐々木淳, 齋藤久夫, 舟生富寿, 畠山真吾, 米山高弘, 古家琢也, 神村典孝, 大山力, 小野睦, 籐哲

日本泌尿器科学会雑誌 102 ( 2 ) 456 2011

PP-213 膀胱癌の浸潤能に関与するinvadopodia形成にはformin-binding protein 17が必須である(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

山本勇人, 吉川和曉, 須藤美穂子, 橋本安弘, 坪井滋, 山谷金光, 齋藤久夫, 舟生富壽, 畠山真吾, 米山高弘, 古家琢也, 神村典孝, 大山力

日本泌尿器科学会雑誌 102 ( 2 ) 439 2011

PP-040 膀胱癌細胞における浸潤能と浸潤突起の形成について(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

須藤美穂子, 橋本安弘, 米山高弘, 山本勇人, 畠山真吾, 古家琢也, 山谷金光, 齋藤久夫, 舟生富寿, 中村敏也, 佐藤達資, 大山力, 坪井滋

日本泌尿器科学会雑誌 102 ( 2 ) 409 2011

PP-038 ナノパーティクルBCGはBCG生菌無効の細胞株に対して直接効果を有する(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

盛和行, 米山徹, 今西賢悟, 得居範子, 杉山尚樹, 立和田得志, 畠山真吾, 工藤茂将, 米山高弘, 古家琢也, 神村典孝, 中川昌之, 大山力

日本泌尿器科学会雑誌 102 ( 2 ) 409 2011

The Giant Schwannoma in the Pelvic Cavity : A Case Report

Suzuki Yuichiro, Sugiyama Naoki, Okamoto Akiko, Yamamoto Hayato, Hatakeyama Shingo, Yoneyama Takahiro, Hasimoto Yasuhiro, Koie Takuya, Kamimura Noritaka, Ohyama Chikara

Hinyokika Kiyo 56 ( 10 ) 581 - 583 2010.10

Experience of Laparoscopic Surgery of Pheochromocytoma Found on Induction for Hemodialysis

Sugiyama Naoki, Suzuki Yuichiro, Okamoto Akiko, Yamamoto Hayato, Kudo Shigemasa, Hatakeyama Shingo, Yoneyama Takahiro, Hashimoto Yasuhiro, Koie Takuya, Kamimura Noritaka, Ohyama Chikara

Hinyokika Kiyo 56 ( 10 ) 565 - 567 2010.10

Significance of a Simple Assay of Urine Telomerase Activity for the Detection of Bladder Cancer

Iwabuchi Ikuya, Mori Kazuyuki, Yamamoto Hayato, Hatakeyama Shingo, Yoneyama Takahiro, Hashimoto Yasuhiro, Koie Takuya, Kamimura Noritaka, Suzuki Tadashi, Ohyama Chikara

Hinyokika Kiyo 56 ( 10 ) 551 - 557 2010.10

Tumor formation assays.

Hatakeyama S, Yamamoto H, Ohyama C.

Methods Enzymol 2010.9

Core 2 N-acetylglucosaminyltransferase-1 (C2GnT-1) expression induces aggressive potential of testicular germ cell tumor.

Hatakeyama S, Kyan A, Yamamoto H, Okamoto A, Sugiyama N, Suzuki Y, Yoneyama T, Hashimoto Y, Koie T, Yamada S, Saito H, Arai Y, Fukuda M, Ohyama C.

Int J Cancer 2010.9

Uterus-, Fallopian Tube-, Ovary-, and Vagina-Sparing Cystectomy Followed by U-shaped Ileal Neobladder Construction for Female Bladder Cancer Patients: Oncological and Functional Outcomes

Koie T, Hatakeyama S, Yoneyama T, Hashimoto Y, Kamimura N, Ohyama C.

Urology. 2010.6

Cauda equina symptoms are closely related to male lower urinary tract symptoms.

Imai A, Yamamoto H, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Danjo K, Ono A, Ohyama C.

Urol Int 2010.3

Invadopodia formation by bladder tumor cells

Sutoh M, Hashimoto Y, Yoneyama T, Yamamoto H, Hatakeyama S, Koie T, Okamoto A, Yamaya K, Saitoh H, Funyu T, Nakamura T, Sato T, Ohyama C, Tsuboi S.

Oncol Res 2010.2

Surgical treatment of a giant liposarcoma in a Japanese man

. Hashimoto Y, Hatakeyama S, Tachiwada T, Yoneyama T, Koie T, Kamimura N, Yanagisawa T, Hakamada K, Ohyama C.

Adv Urol. 2010.1

Expression of the Y-Encoded TSPY is Associated with Progression of Prostate Cancer

Kido T, Hatakeyama S, Ohyama C, Lau YF.

Genes 2010.1

Multiple Inflammatory Pseudotumor of the Paranephric Fat

Yamamoto Hayato, Suzuki Yuichiro, Sugiyama Naoki, Okamoto Akiko, Hatakeyama Shingo, Iwabuchi Ikuya, Yoneyama Takahiro, Koie Takuya, Hashimoto Yasuhiro, Momose Akishi, Kamimura Noritaka, Ohyama Chikara

Hinyokika Kiyo 55 ( 12 ) 757 - 759 2009.12

Risk factors for erectile dysfunction in healthy Japanese men.

Imai A, Yamamoto H, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Danjyo K, Ohyama C.

Int J Androl. 2009.8

Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex.

Lee SH, Hatakeyama S, Yu SY, Bao X, Ohyama C, Khoo KH, Fukuda MN, Fukuda M.

J Biol Chem 19 ( 6 ) 17157 - 17169 2009.6

Endothelial cyst of the adrenal gland associated with adrenocortical adenoma: preoperative images simulate carcinoma.

Nigawara T, Sakihara S, Kageyama K, Terui K, Takayasu S, Hatakeyama S, Ohyama C, Sasano H, Suda T.

Intern Med. 48 ( 4 ) 235 - 240 2009.4

Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.

Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Mori K, Yamaya K, Ohyama C.

Oncol Rep 21 ( 1 ) 73 - 79 2009.1

PP-444 High risk前立腺癌に対するLHRH+エストラムスチンのネオアジュバント療法+根治的前立腺全摘除術の有用性(前立腺腫瘍/薬物療法2,一般演題ポスター,第97回日本泌尿器科学会総会)

岡本亜希子, 山本勇人, 百瀬昭志, 今井篤, 畠山真吾, 岩渕郁哉, 米山高弘, 橋本安弘, 盛和行, 古家琢也, 神村典孝, 大山力

日本泌尿器科学会雑誌 100 ( 2 ) 427 2009

PP-463 トロフィニンと精子の運動能について(不妊2,一般演題ポスター,第97回日本泌尿器科学会総会)

畠山真吾, 今井篤, 米山高弘, 橋本安弘, 赤間智也, スンホーリー, 福田道子, 大山力

日本泌尿器科学会雑誌 100 ( 2 ) 432 2009

Enhancement of human sperm motility by trophinin binding peptide

Hatakeyama S, Sugihara K, Lee SH, Nadano D, Nakayama J, Ohyama C, Fukuda MN.

J Urol 180 ( 2 ) 761 - 771 2008.8

Positive expressions of N-acetylglucosaminyltransferase-V (GnT-V) and beta1-6 branching N-linked oligosaccharides in human testicular germ cells diminish during malignant transformation and progression "jointly worked"

Kyan A, Kamimura N, Hagisawa S, Hatakeyama S, Koie T, Yoneyama T, Arai Y, Nakagawa H, Nishimura S, Miyoshi E, Hashimoto Y, Ohyama C.

Int J Oncol 32 ( 1 ) 129 - 134 2008.1

The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors.

Li Y, Tabatabai ZL, Lee TL, Hatakeyama S, Ohyama C, Chan WY, Looijenga LH, Lau YF

Human pathology 38 ( 10 ) 1470 - 81 2007.10

PP-536 トロフィニン結合ペプチドの精子運動能改善効果(第95回日本泌尿器科学会総会)

畠山真吾, 岡本亜希子, 今井篤, 石村大史, 萩沢茂, 米山高弘, 古家琢也, 大和隆, 大山力, 杉原一廣, 福田道子

日本泌尿器科学会雑誌 98 ( 2 ) 530 2007

PP-068 進行性腎細胞癌の予後因子の検討(第95回日本泌尿器科学会総会)

大和隆, 岡本亜希子, 今井篤, 石村大史, 畠山真吾, 岩渕郁哉, 米山高弘, 盛和行, 古家琢也, 大山力

日本泌尿器科学会雑誌 98 ( 2 ) 413 2007

PP-043 α-Galactosylceramide (α-GalCel) のマウス進行性腎癌株RENCAに対する抗腫瘍効果の検討(第95回日本泌尿器科学会総会)

井上高光, 畠山真吾, 齋藤満, 熊澤光明, 湯浅健, 松浦忍, 土谷順彦, 大山力, 羽渕友則

日本泌尿器科学会雑誌 98 ( 2 ) 407 2007

学会印象記「第94回日本泌尿器科学会総会」見聞録

畠山真吾

臨床泌尿器科 60 ( 7 ) 512 - 513 2006.6

S2-4 当科の回腸新膀胱造設術 : 作成法及びウロダイナミックスタディを用いた下部尿路機能の変化について(シンポジウム2「尿路変向術の長期成績とQOL」,第94回日本泌尿器科学会総会)

古家琢也, 岡本亜希子, 今井篤, 石村大史, 畠山真吾, 萩沢茂, 米山高弘, 橋本安弘, 大和隆, 大山力

日本泌尿器科学会雑誌 97 ( 2 ) 133 2006

精巣腫瘍の転移と着床関連分子 Trophinin の相関についての検討(第93回日本泌尿器科学会総会)

畠山真吾, 大山力, 皆川真吾, 井上高光, 柿沼秀秋, 土谷順彦, 羽渕友則, 喜屋武淳, 荒井陽一

日本泌尿器科学会雑誌 96 ( 2 ) 147 2005

　PREV-NEXT　

<HATAKEYAMA SHINGO>

Papers - HATAKEYAMA SHINGO